0001144204-12-010109.txt : 20120221 0001144204-12-010109.hdr.sgml : 20120220 20120221145029 ACCESSION NUMBER: 0001144204-12-010109 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 9 CONFORMED PERIOD OF REPORT: 20111231 FILED AS OF DATE: 20120221 DATE AS OF CHANGE: 20120221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: China Domestica Bio-technology Holdings, Inc. CENTRAL INDEX KEY: 0001380706 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISCELLANEOUS AMUSEMENT & RECREATION [7990] IRS NUMBER: 205432794 STATE OF INCORPORATION: NV FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-53364 FILM NUMBER: 12626472 BUSINESS ADDRESS: STREET 1: ROOM 2303, 2304 SHENFANG SQUARE STREET 2: 3005 RENMING ROAD SOUTH, CITY: LUFUNG DISTRICT, SHENZHEN, STATE: F4 ZIP: 518001 BUSINESS PHONE: 86-13168096855 MAIL ADDRESS: STREET 1: ROOM 2303, 2304 SHENFANG SQUARE STREET 2: 3005 RENMING ROAD SOUTH, CITY: LUFUNG DISTRICT, SHENZHEN, STATE: F4 ZIP: 518001 FORMER COMPANY: FORMER CONFORMED NAME: Cienega Creek Holdings, Inc. DATE OF NAME CHANGE: 20061109 10-Q 1 v303129_10q.htm FORM 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2011

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission File No. 000-53364

CHINA DOMESTICA BIO-TECHNOLOGY HOLDINGS, INC.

(Exact name of Registrant as Specified in its Charter)

Nevada

20-5432794

(State or other Jurisdiction of

Incorporation or Organization)

(I.R.S. Employer Identification No.)

Room 2303, 2304 ShenFang Square, 3005 RenMing

Road South, LuFung District, Shenzhen, China 518001

(Address of Principal Executive Offices) (Zip Code)

(86) 13168096855

(Registrant’s Telephone Number, Including Area Code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ¨	Accelerated Filer ¨
Non-Accelerated Filer ¨	Smaller reporting company x

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes x No ¨

As of February 13, 2012, the registrant had 49,899 shares of common stock outstanding.

CHINA DOMESTICA BIO-TECHNOLOGY HOLDINGS, INC.

INDEX

		Page

PART I – FINANCIAL INFORMATION

Item 1.	Financial Statements.
	Balance Sheets.	3

	Statements of Operations.	4

	Statement of Stockholders’ Equity (Deficit).	6

	Statement of Cash Flows.	5

	Notes to Financial Statements.	7

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations.	9

Item 3.	Quantitative and Qualitative Disclosures About Market Risk.	11

Item 4.	Controls and Procedures.	11

PART II – OTHER INFORMATION

Item 1.	Legal Proceedings.	13

Item 1A.	Risk Factors.	13

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds.	13

Item 3.	Defaults Upon Senior Securities.	13

Item 5.	Other Information.	13

Item 6.	Exhibits.	13

	SIGNATURES	14

PART I.

FINANCIAL INFORMATION

Item 1. Financial Statements

CHINA DOMESTICA BIO-TECHNOLOGY HOLDINGS, INC

BALANCE SHEETS

	As of
	Dec 31 2011			Mar 31 2011
	(Unaudited)			(Audited)
Current assets		215			215
Cash and cash equivalents
Total current assets		215			215

Fixed assets
Computer equipment
Less: accumulated depreciation
Net fixed assets
Total fixed assets

Total assets		215			215

Liabilities
Accounts payable and accrued liabilities		200			200
Due to related parties		0			0
Other payables		93,612			65,988
Total liabilities		93,812			66,188

Stockholders' equity(deficit)
Common stock		51			51
Additional paid-in capital		428,874			428,874
Accumulated deficit during the development stage		(522,522	)		(494,898	)
Total stockholders' equity(deficit)		(93,597	)		(65,973	)

Total liabilities and stockholders' equity(deficit)		215			215

See Notes to Financial Statements

CHINA DOMESTICA BIO-TECHNOLOGY HOLDINGS, INC

STATEMENTS OF OPERATIONS

(Unaudited)

	Three months ended Dec 31						Nine months ended Dec 31						From inception (August 17, 2006) to December 31,
	2011			2010			2011			2010			2011
Revenues

Operating expenses
Officer salaries														50,000
Professional fees		11,528			1,675			27,124			9,831			129,713
Professional fees related party														306,700
Depreciation expense														2,936
General&administrative expenses		500						500						36,470
Total operating expenses		12,028			1,675			27,624			9,831			525,819

Loss from operation		(12,028	)		(1,675	)		(27,624	)		(9,831	)		(525,819	)

Other income(expense)
Interest income														1,540
Cancellation of Debt											4,600			4,600
Loss on disposal of fixed assets														(1,516	)
Impairment expense														(1,327	)
Total other income(expense)								-			4,600			3,297

Loss before income taxes		(12,028	)		(1,675	)		(27,624	)		(5,231	)		(522,522	)

Provision(benefit)for income Taxes											-

Net loss		(12,028	)		(1,675	)		(27,624	)		(5,231	)		(522,522	)

Earnings(loss) per common share
Common shares outstanding		(0.24	)		(0.03	)		(0.55	)		(0.10	)
Basic and fully diluted weighted average

Common shares outstanding (after effect of 1 for 46 share reverse stock split occurring June 29, 2010)		49,896			49,896			49,896			49,896

See Notes to Financial Statements

China Domestica Bio-technology Holdings, Inc.

(A Development Stage Company)

Statement of Cash Flows

From Inception (August 17, 2006) to December 31, 2011

													From Inception
	For three months ended						For nine months ended						(August 17, 2006)
	Dec 31						Dec 31						to December 31,
	2011			2010			2011			2010			2011
Cash Flows Provided By (Used In) Operating Activities
Net income (loss)		(12,028	)		(1,675	)		(27,624	)		(5,231	)		-522,522
														0
Adjustments to reconcile net income (loss) to net cash provided from (used by) operating activities:														0
Common stock issued for services														257,000
Cancellation of Debt											(4,600	)		-4,600
Depreciation and amortization														2,936
Impairment of fixed assets														1,327
Loss on disposal of fixed assets														1,516
Changes in operating assets and liabilities:														0
Prepaid officer's salaries														0
Increase (decrease) in accounts payable		12,028			1,675			27,624			9,831			66,188
Net cash provided by (used in) operating activities		0			0			0			0			-198,155

Cash Flows Provided By (Used In) Investing Activities
Purchase of fixed assets														-7,179
Sale of fixed assets														1400
Net cash provided by (used in) investing activities		0			0			0			0			-5,779

Cash Flows Provided By (Used In) Financing Activities
Proceeds from loan by related party														9,100
Common stock purchased and retired														-7,000
Issuance of common stock for cash														174,425
Net cash provided by (used in) financing activities		0			0			0			0			176,525

Net increase (decrease) in cash and cash equivalents														0
Cash and cash equivalents, beginning of period		215			215			215			215			215
Cash and cash equivalents, end of period		215			215			215			215			215

Supplemental disclosure of Cash Flow Information
Interest paid
Income taxes paid

Schedule of Non Cash investing and financing activities
Common stock issued for services														257,000
Cancellation of Debt											4,600			4,600
Impairment of fixed assets														1,327
Loss on disposal of fixed assets														1,516
Forgiveness of debt from related party														4,500

See Notes to Financial Statements

China Domestica Bio-technology Holdings, Inc.

(A Development Stage Company)

Statement of Stockholders' Equity (Deficit)

From Inception (August 17, 2006) to December 31, 2011

	Common Share		Stock Amount		Additional Paid-in Capital		Deficit Accumulated during Development Stage		Total
Balance, August 17, 2006
Common shares issued for cash, $0.46 per share between August 2006 and March 2007		156,522		157		71,843				72,000
Net loss for the period from inception on August 17, 2006 through March 31, 2007								-2,640		-2,640
Balance, March 31, 2007		156,522		157		71,843		-2,640		69,360
Net loss for the year ended March 31, 2008								-20,744		-20,744
Balance, March 31, 2008		156,522		157		71,843		-23,384		48,616
Common shares issued for services, $4.6 per share on June 12, 2008		1,522		2		6,998				7,000
Common shares issued for cash, $4.6 per share on June 30, 2008		22,266		22		102,403				102,425
Common shares issued for services at $11.5 per share on January 1, 2009		21,739		22		249,978				250,000
Common shares repurchased and retired at $0.046 per share on March 11, 2009		-152,174		-152		-6,848				-7,000
Additional shares issued in the 1 for 46 share reverse stock split due to rounding up of fractional shares		21								0
Net loss for the year ended March 31, 2009								-349,607		-349,607
Balance, March 31, 2009 (Restated)		49,896		51		424,374		-372,991		51,434
Forgiveness of debt from related party						4,500				4,500
Net loss for the period ended March 31, 2010								-60,519		-60,519
Ending Balance, March 31, 2010		49,896		51		428,874		-433,510		-4,585
Net loss for the period ended March 31, 2011								-61,388		-61,388
Ending Balance, March 31, 2011		49,896		51		428,874		-494,898		-65,973
Net loss for the period ended June 30, 2011								-297		-297
Ending Balance, June 30, 2011		49,896		51		428,874		-495,195		-66,270
Net loss for the period ended September 30,2011								-15,299		-15,299
Ending Balance, September 30, 2011		49,896		51		428,874		-510,494		-81,569
Net loss for the period ended December 31,2011								-12,028		-12,028
Ending Balance, December 31, 2011		49,896		51		428,874		-522,522		-93,597

See Notes to Financial Statements

Note 1. Interim Unaudited Financial Statements

The consolidated balance sheet of CHINA DOMESTICA BIO-TECHNOLOGY HOLDINGS, INC. (the “Company”) as of December 31, 2011, and the statements of operations and cash flows for the nine -months period ended December 31, 2011, have not been audited. However, in the opinion of management, such information includes all adjustments (consisting only of normal recurring adjustments) which are necessary to properly reflect the financial position of the Company as of December 31, 2011, and the results of operations for the three-months ended December 31, 2011.

Certain information and notes normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, although management believes that the disclosures are adequate to make the information presented not misleading. Interim period results are not necessarily indicative of the results to be achieved for an entire year. These financial statements should be read in conjunction with the financial statements and notes to financial statements included in the Company’s financial statements as filed on Form 10-K for the fiscal year ended March 31, 2011.

Note 2.Going-concern

We incurred a net loss of approximately $ 27,624 and $61,388 for the 9-months ended December 31, 2011 and for the fiscal year ended March 31, 2011, respectively and a cumulative net loss of approximately $522,522 since inception (August 17, 2006) through December 31, 2011, and there is substantial doubt about our ability to continue as a going concern. As of December 31, 2011, we had approximately $215 in cash and cash equivalents. In order to continue to operate, we need to develop additional sources of capital and to ultimately achieve profitable operations. We do not have sufficient resources to fund our operations for the next twelve months.

We estimate that we will require minimum funding in fiscal year 2011 of approximately $30,000 in order to fund our operations. Although we are actively seeking new sources of equity and reduce our expenses while seeking a suitable merger candidate, there can be no assurances that we will be able to raise additional capital on terms that are acceptable to us or at all. Additionally, there can be no assurance that we will be able to find a suitable merger candidate.

Note 3. Summary of Significant Accounting Policies

The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgments. Actual results may vary from these estimates. The financial statements have, in management's opinion, been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below:

Development Stage Company

The Company is a development stage company as defined by ASC 915-10-05,"Development Stage Entity". The Company is still devoting substantially all of its efforts on establishing the business and its planned principal operations have not commenced. All losses accumulated, since inception, have been considered as part of the Company's development stage activities.

Revenue Recognition

Presently, the Company is in the development stage and as such, has no revenues. Upon emerging from the development stage the Company will adopt a policy of recognizing revenue when a definitive agreement with a determinable price exists, product delivery and/or invoicing (in each case where there is reasonable assurance of meeting customer-specified criteria) has occurred, and the collectability of the invoice is reasonably assured.

Use of Estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

Recent Accounting Pronouncements

The Company’s management has evaluated recently issued accounting standards through the filing date of these financial statements and believes that the recently issued accounting standards will not have a material impact on the Company’s financial position, operations, or cash flows.

Note 4. Commitments and Contingencies

There is no commitment or contingencies to disclose during the nine-months ended December 31, 2011.

Note 5. Subsequent Events

Management has evaluated subsequent events and the impact on the reported results and disclosures and determined that there have not been any events that would be required to be reflected in the financial statements or the notes.

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations.

The following should be read in conjunction with the financial statements of the Company included elsewhere herein.

FORWARD-LOOKING STATEMENTS

When used in this report, the words “may,” “will,” “expect,” “anticipate,” “continue,” “estimate,” “intend,” “plans”, and similar expressions are intended to identify forward-looking statements regarding events, conditions and financial trends which may affect our future plans of operations, business strategy, operating results and financial position. Forward looking statements in this report include without limitation statements relating to trends affecting our financial condition or results of operations, our business and growth strategies and our financing plans.

Such statements are not guarantees of future performance and are subject to risks and uncertainties and actual results may differ materially from those included within the forward-looking statements as a result of various factors. Such factors include statements other than historical information or statements of current conditions and may relate to our future plans, operations and objectives and results, among other things, our plans to consider possible acquisitions, statements with respect to our expectations or beliefs with respect to future competition and statements concerning our need for and ability to attract additional capital, and other risks and factors set forth from time to time in our filings with the Securities and Exchange Commission.

Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. We undertake no obligation to publicly release the result of any revision of these forward-looking statements to reflect events or circumstances after the date they are made or to reflect the occurrence of unanticipated events.

Overview and Recent History

China Domestica Bio-technology Holdings, Inc. was incorporated in the State of Nevada on August 17, 2006 under the name “Cienega Creek Holdings, Inc.” The Company was previously engaged in the computer software business. On March 16, 2010, the Company entered into a material definitive agreement (the “Belmont Stock Purchase Agreement”) with Michael Klinicki and Belmont Partners, LLC (“Belmont”) whereby Belmont purchased a controlling interest of the Company’s common stock (the “Belmont Purchase Transaction”) from Michael Klinicki on March 18, 2010. Pursuant to the Belmont Stock Purchase Agreement, Joseph Meuse, a managing member of Belmont, was appointed as a member of the Company’s Board of Directors and to the office of President and all other Directors and officers of the Company resigned. Concurrent with this change of management, the Company moved its principal executive offices to 360 Main Street, Washington, VA 22747. Contemporaneously with the Belmont Purchase Transaction, the Company changed its plan of business from the development and marketing of computer software to seeking to acquire or merge with a revenue-producing company.

On April 26, 2010, the Company entered into a Common Stock Purchase Agreement (the “Purchase Agreement”) by and among China Sheng Yong Bio-Pharmaceutical Holding Company Limited, or the “Buyer,” Belmont, or the Seller, and the Company. Pursuant to the terms of the Purchase Agreement, on April 26, 2010, the Buyer acquired from the Seller a controlling interest in the Company’s common stock. Pursuant to the terms of the Purchase Agreement, the Company agreed to issue to the Seller shares of its common stock such that the Seller will own 5% of the issued and outstanding capital stock of the Company after the closing of a merger transaction with an as of yet unidentified target corporation contemplated by the Purchase Agreement. Pursuant to the terms of the Purchase Agreement, Joseph J. Meuse resigned on the Closing Date and Qingyu Meng was named President and Director of the Company and Yung Kong Chin was named Secretary and Director of the Company. Such resignation and appointments were effective as of the Closing Date with respect to the officers of the Company. The resignation of Joseph J. Meuse as a director and the naming of Messrs. Meng and Chin as directors took effect on May 22, 2010. Concurrent with this change of management, the Company moved its principal executive offices to Room 2303, 2304 ShenFang Square, 3005 RenMing Road South, LuFung District, Shenzhen, China. The Company’s telephone number is (86) 13168096855. The Company’s fiscal year end is March 31.

On June 29, 2010, the Company amended its articles of incorporation to change its name to “China Domestica Bio-technology Holdings, Inc.,” to authorize the issuance of up to 10,000,000 shares of “blank check” preferred stock and to effect a 46-for-1 reverse stock split of its outstanding shares of common stock. The reverse stock split reduced the number of issued and outstanding shares of our Common Stock from 2,294,250 shares outstanding prior to the split to 49,896 shares outstanding after the split. The reverse stock split became effective on June 29, 2010.

Plan of Operations

We are a start-up, exploration-stage corporation and have not yet generated or realized any revenues from our business operations.

Whereas sales and marketing activities were our focus during fiscal 2009, we were unable to realize any revenues as a result of these activities. As a result of our lack of revenues and inability to secure additional funding to allow business operations to continue, our Board of Directors determined that it was necessary to terminate the execution of our prior business plan, and that a change in business focus was needed and in the best interests of the Company and its shareholders. The goal of the new business plan is to merge with or acquire a revenue-producing business or a development stage business with a high potential for growth.

We will need additional capital in fiscal 2012. As of December 31, 2011, we had $215in cash and cash equivalents. During recent fiscal years, we made certain cost reductions. We have no remaining employees. Our former CEO Michael Klinicki agreed to terminate his employment agreement effective as of January 1, 2010. In addition, during the quarter ended September 30, 2010, Mr. Klinicki agreed to the cancellation of $4,600 in debts payable to him by the Company.

Although we continue to look for ways to raise additional capital, we recognize that it is not likely this will be successful. As an alternative strategy, we have decided to focus on identifying suitable candidates to merge with or acquire. We believe that our ability to continue to operate depends on finding a suitable merger target with the ability to raise additional needed capital. Notwithstanding the elimination of most of our remaining expenses, we may need additional cash during the next twelve months. As a result of our current limited cash availability we do not anticipate hiring any employees for the foreseeable future.

Results of Operations

Comparison of Three Months Ended December 31, 2011 and December 31, 2010 (Unaudited)

We did not earn any revenues during the three-month periods ending December 31, 2011 and 2010. During the three-month period ended December 31, 2011, we incurred operating expenses in the amount of $12,028, compared to operating expenses of $1,675 incurred during the same period in 2010. These operating expenses were comprised primarily of professional fees.

Comparison of Nine Months Ended December 31, 2011 and December 31, 2010 (Unaudited)

We did not earn any revenues during the nine-month periods ending December 31, 2011 and 2010. During the nine-month period ended December 31, 2011, we incurred operating expenses in the amount of $27,624, which was approximately $17,793, or 181%, more than the Company’s operating expenses of $9,831 incurred during the same period in 2010. These operating expenses were comprised primarily of professional fees.

Liquidity and Capital Resources

At its current level of operations, the Company will need to begin profitable operations and/or raise additional capital during the next fiscal year. As of December 31, 2011, the Company had not generated any revenue and had $215 in cash and cash equivalents and owed accounts payable and accrued liabilities of $200 and other payables of $93,812. Despite the reductions in expenses mentioned above, we will not have enough capital resources available to continue operating through the end of our next fiscal year. We estimate that we will require minimum additional funding in fiscal year 2012 of approximately $30,000 to fund our operations. Our ability to continue operating depends on our ability to locate and merge with a business generating revenues. If the Company is successful in finding a suitable merger target, it may result in significant dilution to existing shareholders.

Going Concern

We incurred a net loss of approximately $12,028 for the three months ended December 31, 2011, and a cumulative net loss of approximately $522,522 since inception (August 17, 2006) through December 31, 2011, and there is substantial doubt about our ability to continue as a going concern. As of December 31, 2011, we had approximately $215 in cash and cash equivalents. In order to continue to operate we need to develop additional sources of capital and to ultimately achieve profitable operations. We do not have sufficient resources to fund our operations for the next twelve months.

We estimate that we will require minimum funding in fiscal year 2012 of approximately $30,000 in order to fund our operations. Although we are actively seeking new sources of equity and reduce our expenses while seeking a suitable merger candidate, there can be no assurances that we will be able to raise additional capital on terms that are acceptable to us or at all. Additionally, there can be no assurance that we will be able to find a suitable merger candidate.

Off-Balance Sheet Arrangements

At December 31, 2011, we did not have any transactions, obligations or relationships that could be considered off-balance sheet arrangements.

Critical Accounting Policies

Our financial statements are prepared in accordance with accounting principles generally accepted in the United States of America. Preparing financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions which affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the balance sheet dates, and the recognition of revenues and expenses for the reporting periods. These estimates and assumptions are affected by management's application of accounting policies.

Revenue Recognition

Recent Accounting Pronouncements

Item 3. Quantitative and Qualitative Disclosure About Market Risk.

Not applicable.

Item 4. Controls and Procedures.

(a) Evaluation of Disclosure Controls and Procedures.

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed pursuant to the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules, regulations and related forms, and that such information is accumulated and communicated to our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

As of December 31, 2011, we carried out an evaluation, under the supervision and with the participation of our principal executive officer and our principal financial officer of the effectiveness of the design and operation of our disclosure controls and procedures. During this evaluation, several material weaknesses were identified. As a result of the material weaknesses, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were ineffective as of the end of the period covered by this report.

A material weakness is a deficiency, or combination of deficiencies, in disclosure controls and procedures, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim financial statements will not be prevented or detected on a timely basis. Based on management’s assessment over financial reporting, management believes as of December 31, 2011, the Company’s disclosure controls and procedures were not effective due to the following material weaknesses:

Insufficient Resources: We have an inadequate number of personnel with requisite expertise in the key functional areas of finance and accounting.

Inadequate Segregation of Duties: We have an inadequate number of personnel to properly implement control procedures.

Lack of Audit Committee and Outside Directors on the Company’s Board of Directors: We do not have a functioning audit committee or outside directors on our board of directors, resulting in ineffective oversight in the establishment and monitoring of required internal controls and procedures.

Insufficient Written Policies: We have insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of US GAAP and SEC disclosure requirements.

(b) Changes in Internal Control Over Financial Reporting.

There were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter, which were identified in connection with management’s evaluation required by paragraph (d) of Rules 13a-15 or Rule 15d-15 under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings.

We are not currently involved in any material pending legal proceeding.

Item 1A. Risk Factors.

As a smaller reporting company, we are not required to provide risk factors.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None.

Item 3. Defaults Upon Senior Securities.

None.

Item 5. Other Information.

None.

Item 6. Exhibits.

Exhibits:

31.1* Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 302 of Sarbanes Oxley Act of 2002.

32.1* Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of Sarbanes Oxley Act of 2002.

101.INS*	XBRL Instance Document

101.SCH*	XBRL Taxonomy Extension Schema

101.CAL*	XBRL Taxonomy Extension Calculation Linkbase

101.DEF*	XBRL Taxonomy Extension Definition Linkbase

101.LAB*	XBRL Taxonomy Extension Label Linkbase

101.PRE*	XBRL Taxonomy Extension Presentation Linkbase

*Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: February 21, 2012

	CHINA DOMESTICA BIO-TECHNOLOGY HOLDINGS, INC.

	By:	/s/ Yung Kong Chin
		Qingyu Meng
		President and Secretary
		(Principal Executive Officer and Principal Financial and Accounting Officer)

EX-31.1 2 v303129_ex31-1.htm EXHIBIT 31.1

CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Yung Kong Chin, certify that:

1. I have reviewed this report on Form 10-Q of China Domestica Bio-technology Holdings, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation: and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: February 21, 2012

/s/ Yung Kong Chin
Name: Yung Kong Chin
Title: President and Secretary
(Principal Executive Officer and Principal Financial and Accounting Officer)

EX-32.1 3 v303129_ex32-1.htm EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, Yung Kong Chin, President and Secretary of China Domestica Bio-technology Holdings, Inc., Inc., a Nevada corporation (the "Company"), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) the report on Form 10-Q of Company for the fiscal quarter ended December 31, 2011 (the "Report") which this statement accompanies fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: February 21, 2012

/s/ Yung Kong Chin
Name: Yung Kong Chin
Title: President and Secretary
(Principal Executive Officer and Principal Financial and Accounting Officer)

EX-101.INS 4 cdbh-20111231.xml XBRL INSTANCE DOCUMENT 0001380706 2006-09-01 2007-03-31 0001380706 2007-04-01 2008-03-31 0001380706 us-gaap:RetainedEarningsMember 2007-04-01 2008-03-31 0001380706 2008-04-01 2009-03-31 0001380706 us-gaap:CommonStockMember 2008-04-01 2009-03-31 0001380706 us-gaap:RetainedEarningsMember 2008-04-01 2009-03-31 0001380706 us-gaap:AdditionalPaidInCapitalMember 2008-04-01 2009-03-31 0001380706 2009-04-01 2010-03-31 0001380706 us-gaap:RetainedEarningsMember 2009-04-01 2010-03-31 0001380706 us-gaap:AdditionalPaidInCapitalMember 2009-04-01 2010-03-31 0001380706 2010-10-01 2010-12-31 0001380706 2010-04-01 2010-12-31 0001380706 2010-04-01 2011-03-31 0001380706 us-gaap:RetainedEarningsMember 2010-04-01 2011-03-31 0001380706 2011-03-31 0001380706 2011-04-01 2011-06-30 0001380706 us-gaap:RetainedEarningsMember 2011-04-01 2011-06-30 0001380706 2011-07-01 2011-09-30 0001380706 us-gaap:RetainedEarningsMember 2011-07-01 2011-09-30 0001380706 2011-10-01 2011-12-31 0001380706 us-gaap:RetainedEarningsMember 2011-10-01 2011-12-31 0001380706 2011-04-01 2011-12-31 0001380706 2011-12-31 0001380706 2006-08-17 2011-12-31 0001380706 2012-02-13 0001380706 2007-03-31 0001380706 us-gaap:CommonStockMember 2007-03-31 0001380706 us-gaap:RetainedEarningsMember 2007-03-31 0001380706 us-gaap:AdditionalPaidInCapitalMember 2007-03-31 0001380706 2008-03-31 0001380706 us-gaap:CommonStockMember 2008-03-31 0001380706 us-gaap:RetainedEarningsMember 2008-03-31 0001380706 us-gaap:AdditionalPaidInCapitalMember 2008-03-31 0001380706 2009-03-31 0001380706 us-gaap:CommonStockMember 2009-03-31 0001380706 us-gaap:RetainedEarningsMember 2009-03-31 0001380706 us-gaap:AdditionalPaidInCapitalMember 2009-03-31 0001380706 2010-03-31 0001380706 us-gaap:CommonStockMember 2010-03-31 0001380706 us-gaap:RetainedEarningsMember 2010-03-31 0001380706 us-gaap:AdditionalPaidInCapitalMember 2010-03-31 0001380706 2010-09-30 0001380706 2010-12-31 0001380706 us-gaap:CommonStockMember 2011-03-31 0001380706 us-gaap:RetainedEarningsMember 2011-03-31 0001380706 us-gaap:AdditionalPaidInCapitalMember 2011-03-31 0001380706 2011-06-30 0001380706 us-gaap:CommonStockMember 2011-06-30 0001380706 us-gaap:RetainedEarningsMember 2011-06-30 0001380706 us-gaap:AdditionalPaidInCapitalMember 2011-06-30 0001380706 2011-09-30 0001380706 us-gaap:CommonStockMember 2011-09-30 0001380706 us-gaap:RetainedEarningsMember 2011-09-30 0001380706 us-gaap:AdditionalPaidInCapitalMember 2011-09-30 0001380706 us-gaap:CommonStockMember 2011-12-31 0001380706 us-gaap:RetainedEarningsMember 2011-12-31 0001380706 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0001380706 2006-08-16 xbrli:shares iso4217:USD iso4217:USDxbrli:shares China Domestica Bio-technology Holdings, Inc. 0001380706 --03-31 Smaller Reporting Company cdbh 49899 10-Q false 2011-12-31 Q3 2012

215

200

65988

93612

66188

93812

428874

494898

522522

-65973

-93597

69360

157

-2640

71843

48616

157

-23384

71843

51434

-372991

424374

-4585

-433510

428874

-494898

428874

-66270

-495195

428874

-81569

-510494

428874

-522522

428874

215

50000

1675

9831

11528

27124

129713

306700

2936

500

36470

1675

9831

12028

27624

525819

-1675

-9831

-12028

-27624

-525819

1540

4600 4600

-1516

1327

4600

3297

-1675

-5231

-12028

-27624

-522522

-20744

-349607

-60519

-1675

-5231

-61388

-297

-15299

-12028

-27624

-522522

-0.03

-0.10

-0.24

-0.55

49896 49896 49896 49896 1 for 46 share 1 for 46 share

257000

1675

9831

12028

27624

66188

-198155

7179

1400

-5779

9100

7000

174425

176525

257000

4500

Note 1.  Interim Unaudited Financial Statements   The consolidated balance sheet of CHINA DOMESTICA BIO-TECHNOLOGY HOLDINGS, INC. (the “Company”) as of December 31, 2011, and the statements of operations and cash flows for the nine -months period ended December 31, 2011, have not been audited.  However, in the opinion of management, such information includes all adjustments (consisting only of normal recurring adjustments) which are necessary to properly reflect the financial position of the Company as of December 31, 2011, and the results of operations for the three-months ended December 31, 2011.   Certain information and notes normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, although management believes that the disclosures are adequate to make the information presented not misleading.  Interim period results are not necessarily indicative of the results to be achieved for an entire year.  These financial statements should be read in conjunction with the financial  statements and notes to financial statements included in the Company’s financial statements as filed on Form 10-K for the fiscal year ended March 31, 2011.

Note 2.Going-concern   We incurred a net loss of approximately $ 27,624 and $61,388 for the 9-months ended December 31, 2011 and for the fiscal year ended March 31, 2011, respectively and a cumulative net loss of approximately $522,522 since inception (August 17, 2006) through December 31, 2011, and there is substantial doubt about our ability to continue as a going concern. As of December 31, 2011, we had approximately $215 in cash and cash equivalents. In order to continue to operate, we need to develop additional sources of capital and to ultimately achieve profitable operations. We do not have sufficient resources to fund our operations for the next twelve months.   We estimate that we will require minimum funding in fiscal year 2011 of approximately $30,000 in order to fund our operations.  Although we are actively seeking new sources of equity and reduce our expenses while seeking a suitable merger candidate,  there can be no assurances that we will be able to raise additional capital on terms that are acceptable to us or at all.  Additionally, there can be no assurance that we will be able to find a suitable merger candidate.

Note 3. Summary of Significant Accounting Policies   The financial statements of the Company have been prepared in accordance with generally accepted accounting principles in the United States of America. Because a precise determination of many assets and liabilities is dependent upon future events, the preparation of financial statements for a period necessarily involves the use of estimates which have been made using careful judgments. Actual results may vary from these estimates. The financial statements have, in management's opinion, been properly prepared within reasonable limits of materiality and within the framework of the significant accounting policies summarized below:   Development Stage Company   The Company is a development stage company as defined by ASC 915-10-05,"Development Stage Entity". The Company is still devoting substantially all of its efforts on establishing the business and its planned principal operations have not commenced. All losses accumulated, since inception, have been considered as part of the Company's development stage activities.   Revenue Recognition   Presently, the Company is in the development stage and as such, has no revenues.  Upon emerging from the development stage the Company will adopt a policy of recognizing revenue when a definitive agreement with a determinable price exists, product delivery and/or invoicing (in each case where there is reasonable assurance of meeting customer-specified criteria) has occurred, and the collectability of the invoice is reasonably assured.   Use of Estimates   The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.   Recent Accounting Pronouncements   The Company’s management has evaluated recently issued accounting standards through the filing date of these financial statements and believes that the recently issued accounting standards will not have a material impact on the Company’s financial position, operations, or cash flows.

Note 4. Commitments and Contingencies   There is no commitment or contingencies to disclose during the nine-months ended December 31, 2011

Note 5. Subsequent Events   Management has evaluated subsequent events and the impact on the reported results and disclosures and determined that there have not been any events that would be required to be reflected in the financial statements or the notes.

156522

49896

102425

102403

22266

-7000

-152

-6848

-152174

7000 2 6998 1522 250000 22 249978 21739 0 21 4500 4500 4.6 0.46 4.6 11.5 0.046

0001380706us-gaap:CommonStockMember2006-08-172007-03-31 0001380706us-gaap:RetainedEarningsMember2006-08-172007-03-31

157

156522

00013807062006-08-172007-03-31

72000

-2640

0001380706us-gaap:AdditionalPaidInCapitalMember2006-08-172007-03-31

71843

-2640

EX-101.SCH 5 cdbh-20111231.xsd XBRL TAXONOMY EXTENSION SCHEMA 001 - Document - DOCUMENT AND ENTITY INFORMATION link:presentationLink link:definitionLink link:calculationLink 002 - Statement - BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 003 - Statement - STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 004 - Statement - STATEMENTS OF OPERATIONS [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Statement of Cash Flows link:presentationLink link:definitionLink link:calculationLink 006 - Statement - Statements of Stockholders' Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 007 - Statement - Statement of Stockholders' Equity (Deficit) [Parenthetical] link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Interim Unaudited Financial Statements link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Going concern link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 6 cdbh-20111231_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 7 cdbh-20111231_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 8 cdbh-20111231_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document and Entity Information [Abstract] Document and Entity Information [Abstract] Document And Entity Information Statement [Table] Statement [Table] Statement [Line Items] Statement [Line Items] Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Trading Symbol Trading Symbol Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Statement Of Financial Position [Abstract] Statement of Financial Position [Abstract] Assets [Abstract] Assets [Abstract] Assets, Current [Abstract] Current assets Cash and Cash Equivalents, At Carrying Value Cash and cash equivalents Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Assets, Current Total current assets Total current assets Property, Plant and Equipment, Net [Abstract] Fixed assets Assets, Noncurrent Total fixed assets Assets Total assets Total assets Liabilities [Abstract] Liabilities Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued liabilities Accounts payable and accrued liabilities Due To Related Parties, Current Due to related parties Due to Related Parties, Current, Total Other Liabilities, Current Other payables Other payables Liabilities Total liabilities Total liabilities Stockholders Equity Attributable To Parent [Abstract] Stockholders' equity(deficit) Common Stock, Value, Issued Common stock Common Stock, Value, Issued, Total Common Stock, Value, Issued, Beginning Balance Common Stock, Value, Issued, Ending Balance Additional Paid In Capital, Common Stock Additional paid-in capital Additional Paid in Capital, Common Stock, Beginning Balance Additional Paid in Capital, Common Stock, Ending Balance Development Stage Enterprise, Deficit Accumulated During Development Stage Accumulated deficit during the development stage Accumulated deficit during the development stage Accumulated deficit during the development stage Stockholders Equity Attributable To Parent Total stockholders' equity (deficit) Total stockholders' equity(deficit) Balance Balance Liabilities and Equity Total liabilities and stockholders' equity (deficit) Total liabilities and stockholders' equity(deficit) Income Statement [Abstract] Income Statement [Abstract] Operating Expenses [Abstract] Operating expenses Officers Compensation Officer salaries Professional Fees Professional fees Professional Fees Related Party Professional fees related party The aggregate amount of expenditures for professional fees charged by related party to the entity during the period. Depreciation Depreciation expense Depreciation and amortization Depreciation, Total General and Administrative Expense General&administrative expenses General&administrative expenses Operating Expenses Total operating expenses Total operating expenses Operating Income (Loss) Loss from operation Loss from operation Nonoperating Income (Expense) [Abstract] Other income(expense) Investment Income, Interest Interest income Interest income Cancellation Of Debt Cancellation of Debt Cancellation of Debt Amount of debt to the entity cancelled during the period. Cancellation of Debt Gain (Loss) On Disposition Of Assets Loss on disposal of fixed assets Loss on disposal of fixed assets Asset Impairment Charges Impairment of fixed assets Impairment of fixed assets Impairment expense Impairment expense Impairment expense Nonoperating Income (Expense) Total other income (expense) Total other income(expense) Income (Loss) From Continuing Operations Before Income Taxes, Extraordinary Items, Noncontrolling Interest Loss before income taxes Loss before income taxes Loss before income taxes Sale Of Stock, Deferred Income Tax Provision On Gain (Loss) Recognized Provision(benefit)for income Taxes Provision(benefit)for income Taxes Net Income (Loss) Attributable To Parent Net income (loss) Net loss Net loss Earnings Per Share, Basic and Diluted Earnings(loss) per common share Common shares outstanding (in dollars per share) Weighted Average Number Of Common Shares Outstanding, Basic and Diluted Basic and fully diluted weighted average Common shares outstanding (after effect of 1 for 46 share reverse stock split occurring June 29, 2010) (in shares) Basic and fully diluted weighted average Common shares outstanding (after effect of 1 for 46 share reverse stock split occurring June 29, 2010) (in shares) The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Statement Of Operations (Parenthetical) [Abstract] Statement Of Operations (Parenthetical) [Abstract] Statement Of Operations (Parenthetical) Common Shares Reverse Stock Split Conversion Ratio Common shares, reverse stock split, conversion ratio This item represents the conversion ratio used in the calculation of a reverse stock split. Statement Of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] Cash and Cash Equivalents, Period Increase (Decrease) [Abstract] Net Cash Provided By (Used In) Operating Activities [Abstract] Cash Flows Provided By (Used In) Operating Activities Adjustments To Reconcile Net Income (Loss) To Cash Provided By (Used In) Operating Activities [Abstract] Adjustments to reconcile net income (loss) to net cash provided from (used by) operating activities: Issuance Of Stock and Warrants For Services Or Claims Common stock issued for services Increase (Decrease) In Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) In Prepaid Expense Prepaid officer's salaries Prepaid officer's salaries Increase (Decrease) In Accounts Payable Increase (decrease) in accounts payable Increase (decrease) in accounts payable Net Cash Provided By (Used In) Operating Activities Net cash provided by (used in) operating activities Net cash provided by (used in) operating activities Net Cash Provided By (Used In) Investing Activities [Abstract] Cash Flows Provided By (Used In) Investing Activities Payments To Acquire Property, Plant, and Equipment Purchase of fixed assets Purchase of fixed assets Purchase of fixed assets Proceeds From Sale Of Property, Plant, and Equipment Sale of fixed assets Sale of fixed assets Net Cash Provided By (Used In) Investing Activities Net cash provided by (used in) investing activities Net cash provided by (used in) investing activities Net Cash Provided By (Used In) Financing Activities [Abstract] Cash Flows Provided By (Used In) Financing Activities Proceeds From Related Party Debt Proceeds from loan by related party Payments For Repurchase Of Common Stock Common stock purchased and retired Common stock purchased and retired Proceeds From Issuance Of Common Stock Issuance of common stock for cash Issuance of common stock for cash Net Cash Provided By (Used In) Financing Activities Net cash provided by (used in) financing activities Net cash provided by (used in) financing activities Cash and Cash Equivalents, Period Increase (Decrease) Net increase (decrease) in cash and cash equivalents Net increase (decrease) in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Supplemental disclosure of Cash Flow Information Interest Paid Interest paid Income Taxes Paid Income taxes paid Noncash Investing and Financing Items [Abstract] Schedule of Non Cash investing and financing activities Stock Issued Common stock issued for services Common stock issued for services Forgiveness Of Debt From Related Party Forgiveness of debt from related party Forgiveness of debt from related party Forgiveness of debt from related party Amount of debt forgiven by related party under non-cash investing and financing activity during the period. Statement Of Stockholders Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement, Equity Components [Axis] Statement, Equity Components [Axis] Common Stock [Member] Additional Paid-In Capital [Member] Retained Earnings [Member] Shares, Outstanding Balance(in shares) Balance (in shares) Stock Issued During Period, Value, New Issues Common shares issued for cash, $0.46 per share between August 2006 and March 2007 Common shares issued for cash Stock Issued During Period, Shares, New Issues Common shares issued for cash, $0.46 per share between August 2006 and March 2007 Common shares issued for cash (in shares) Stock Issued During Period Value Serviece One Common shares issued for services, $4.6 per share on June 12, 2008 Equity impact of the value of new stock issued for service one during the period. Includes shares issued in an initial public offering or a secondary public offering. Stock Issued During Period Shares Issue Service One Common shares issued for services, $4.6 per share on June 12, 2008 (in shares) Number of new stock issued service one during the period. Stock Issued During Period Value Serviece Two Common shares issued for services at $11.5 per share on January 1, 2009 Equity impact of the value of new stock issued for service two during the period. Includes shares issued in an initial public offering or a secondary public offering Stock Issued During Period Shares Issue Service Two Common shares issued for services at $11.5 per share on January 1, 2009 (in shares) Number of new stock issued service two during the period Stock Repurchased and Retired During Period, Value Common shares repurchased and retired at $0.046 per share on March 11, 2009 Stock Repurchased and Retired During Period, Shares Common shares repurchased and retired at $0.046 per share on March 11, 2009 (in shares) Additional Shares Issued Additional shares issued in the 1 for 46 share reverse stock split due to rounding up of fractional shares Number of additional shares issued due to rounding up of fractional shares in connection with reverse stock splits during the reporting period. Adjustments To Additional Paid In Capital Forgiveness Of Debt From Related Party Forgiveness of debt from related party Aggregate adjustment to additional paid in capital for Forgiveness of debt from related party during the period. Exercise Price Per Share Of Stock Issued For Service One Exercise price of new stock issued for service one during the period. Exercise price per share of stock issued for service one (in dollars per share) Exercise Price Per Share Of Stock Issued During Period New Issues Exercise price of new stock issued during the period. Exercise price per share of stock issued during period for cash (in dollars per share) Exercise Price Per Share Of Stock Issued For Service Two Exercise price of new stock issued for service two during the period. Exercise price per share of stock issued for service two (in dollars per share) Exercise Price Of Common Shares Repurchased and Retired Exercise price of common shares repurchased and retired during the period. Exercise price of common shares repurchased and retired (in dollars per share) Organization, Consolidation and Presentation Of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Basis Of Accounting [Text Block] Basis of Accounting [Text Block] Going Concern [Abstract] Going Concern [Abstract] Going Concern [Text Block] Going Concern [Text Block] The entire disclosure for going concern. Accounting Policies [Abstract] Accounting Policies [Abstract] Significant Accounting Policies [Text Block] Significant Accounting Policies [Text Block] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events [Text Block] Statement, Scenario [Axis] Scenario, Unspecified [Domain] Machinery and Equipment, Gross Computer equipment Machinery and Equipment, Gross, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance Property, Plant and Equipment, Net Net fixed assets Net fixed assets Net fixed assets Property, Plant and Equipment, Net, Beginning Balance Property, Plant and Equipment, Net, Ending Balance Revenues Revenues Revenues Class of Stock [Axis] Equity Component [Domain] Class of Stock [Domain] Increase (Decrease) in Stockholders' Equity [Roll Forward] Parent [Member] EX-101.PRE 9 cdbh-20111231_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 R9.htm IDEA: XBRL DOCUMENT

Going concern	9 Months Ended
Dec. 31, 2011
Going Concern [Abstract]
Going Concern [Text Block]	Note 2.Going-concern We incurred a net loss of approximately $ 27,624 and $61,388 for the 9-months ended December 31, 2011 and for the fiscal year ended March 31, 2011, respectively and a cumulative net loss of approximately $522,522 since inception (August 17, 2006) through December 31, 2011, and there is substantial doubt about our ability to continue as a going concern. As of December 31, 2011, we had approximately $215 in cash and cash equivalents. In order to continue to operate, we need to develop additional sources of capital and to ultimately achieve profitable operations. We do not have sufficient resources to fund our operations for the next twelve months. We estimate that we will require minimum funding in fiscal year 2011 of approximately $30,000 in order to fund our operations. Although we are actively seeking new sources of equity and reduce our expenses while seeking a suitable merger candidate, there can be no assurances that we will be able to raise additional capital on terms that are acceptable to us or at all. Additionally, there can be no assurance that we will be able to find a suitable merger candidate.

Going concern

9 Months Ended

Dec. 31, 2011

Going Concern [Abstract]

Going Concern [Text Block]

Note 2.Going-concern

EXCEL 12 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\P,S$X.3ED,5\W8S,V7S1B9#%?.#-C-U\U,#8X M938T-S8T-&0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T#I%>&-E;%=O#I7;W)K#I7;W)K#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-T871E;65N='-?;V9?4W1O8VMH;VQD97)S7T5Q=3PO>#I. M86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN=&5R:6U?56YA=61I=&5D7T9I;F%N8VEA;%]3=#PO M>#I.86UE/@T*("`@(#QX.E=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/E-U8G-E<75E;G1?179E;G1S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T M4V]U#I%>&-E;%=O#I!8W1I=F53:&5E=#XP/"]X.D%C=&EV95-H965T/@T*("`\ M>#I0#I%>&-E;%=O7!E M.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@ M/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C M;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!#96YT3PO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,3,X,#'0^+2TP,RTS,3QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^8V1B:#QS<&%N/CPO'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^,C`Q,CQS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA&5D(&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$6%B;&4@86YD(&%C8W)U960@ M;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA6%B;&5S/"]T9#X-"B`@("`@ M("`@/'1D(&-L87-S/3-$;G5M<#XY,RPV,3(\2AD969I8VET*3PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'!E;G-E/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$=&5X=#X\'!E;G-E'!E;G-E*3PO'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M/B@Q,BPP,C@I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S2!D M:6QU=&5D('=E:6=H=&5D(&%V97)A9V4@0V]M;6]N('-H87)E'1087)T7S`S,3@Y.60Q7S=C,S9?-&)D,5\X,V,W7S4P-CAE-C0W-C0T M9`T*0V]N=&5N="U,;V-A=&EO;CH@9FEL93HO+R]#.B\P,S$X.3ED,5\W8S,V M7S1B9#%?.#-C-U\U,#8X938T-S8T-&0O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^,2!F;W(@-#8@'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2D@;W!E'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S6%B M;&4\+W1D/@T*("`@("`@("`\=&0@8VQA2`H=7-E M9"!I;BD@;W!E'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S&5D(&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R M=%\P,S$X.3ED,5\W8S,V7S1B9#%?.#-C-U\U,#8X938T-S8T-&0-"D-O;G1E M;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#,Q.#DY9#%?-V,S-E\T8F0Q7S@S M8S=?-3`V.&4V-#'0O:'1M;#L@8VAA2`H1&5F:6-I="D@*%531"`D*3QB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@(#PO=&%B;&4^#0H@(#PO8F]D>3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\P,S$X.3ED,5\W8S,V7S1B9#%?.#-C-U\U,#8X M938T-S8T-&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#,Q.#DY M9#%?-V,S-E\T8F0Q7S@S8S=?-3`V.&4V-#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R&5R8VES92!P7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA6QE/3-$)VUA2!O9B!N;W)M86P@2!A65A M7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@ M/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=M87)G:6XZ(#!P>#L@9F]N M=#H@,3!P="!T:6UE3LG/CQU/DYO=&4@,BY';VEN9RUC;VYC97)N/"]U/CPO M<#X-"CQP('-T>6QE/3-$)VUA'0M86QI M9VXZ(&QE9G0[)SY792!I;F-U&EM M871E;'D@)"`R-RPV,C0@86YD("0V,2PS.#@@9F]R('1H92`Y+6UO;G1H65A M2`D-3(R+#4R,B!S M:6YC92!I;F-E<'1I;VX@*$%U9W5S="`Q-RP@,C`P-BD@=&AR;W5G:"!$96-E M;6)E6QE/3-$)VUA'0M86QI9VXZ(&QE9G0[ M)SY792!E2P@=&AE3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\P,S$X.3ED,5\W8S,V7S1B9#%?.#-C-U\U,#8X938T-S8T-&0- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO,#,Q.#DY9#%?-V,S-E\T M8F0Q7S@S8S=?-3`V.&4V-#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'`@3L@;6%R9VEN M.B`P<'@[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE#L@9F]N=#H@,3!P="!T:6UE6QE/3-$ M)W1E>'0M86QI9VXZ(&QE9G0[(&UA2!F2!A M;F0@=VET:&EN('1H92!F6QE/3-$)W1E>'0M86QI9VXZ(&IU3PO<#X-"CQP('-T>6QE M/3-$)W1E>'0M86QI9VXZ(&IU2!I2!!4T,@.3$U+3$P+3`U+")$979E;&]P;65N="!3=&%G92!% M;G1I='DB+B!4:&4@0V]M<&%N>2!I3L@;6%R M9VEN.B`P<'@[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&UA2!I&ES=',L('!R;V1U8W0@9&5L:79E M2!A6QE/3-$)W1E>'0M86QI9VXZ(&IU3L@;6%R9VEN.B`P<'@[(&9O;G0Z(#$P<'0@=&EM97,@;F5W(')O M;6%N+"!T:6UE3L@;6%R9VEN.B`P<'@[(&9O M;G0Z(#$P<'0@=&EM97,@;F5W(')O;6%N+"!T:6UE'!E;G-E#L@9F]N=#H@ M,3!P="!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&IU#L@9F]N M=#H@,3!P="!T:6UE6QE/3-$)W1E>'0M86QI9VXZ(&QE9G0[(&UA2!I3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\P,S$X.3ED,5\W8S,V7S1B M9#%?.#-C-U\U,#8X938T-S8T-&0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z M+R\O0SHO,#,Q.#DY9#%?-V,S-E\T8F0Q7S@S8S=?-3`V.&4V-#'0O:'1M M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\ M<"!S='EL93TS1"=M87)G:6XZ(#!P>#L@9F]N=#H@,3!P="!T:6UE7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA'0@0FQO8VM=/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\<"!S='EL93TS1"=M87)G:6XZ(#!P M>#L@9F]N=#H@,3!P="!T:6UE6QE/3-$)VUA'0M86QI9VXZ(&QE9G0[)SY-86YA9V5M96YT(&AA7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N M.G-C:&5M87,M;6EC&UL M/@T*+2TM+2TM/5].97AT4&%R=%\P,S$X.3ED,5\W8S,V7S1B9#%?.#-C-U\U /,#8X938T-S8T-&0M+0T* ` end XML 13 R8.htm IDEA: XBRL DOCUMENT

Interim Unaudited Financial Statements	9 Months Ended
Dec. 31, 2011
Organization, Consolidation and Presentation Of Financial Statements [Abstract]
Basis of Accounting [Text Block]	Note 1. Interim Unaudited Financial Statements The consolidated balance sheet of CHINA DOMESTICA BIO-TECHNOLOGY HOLDINGS, INC. (the “Company”) as of December 31, 2011, and the statements of operations and cash flows for the nine -months period ended December 31, 2011, have not been audited. However, in the opinion of management, such information includes all adjustments (consisting only of normal recurring adjustments) which are necessary to properly reflect the financial position of the Company as of December 31, 2011, and the results of operations for the three-months ended December 31, 2011. Certain information and notes normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted, although management believes that the disclosures are adequate to make the information presented not misleading. Interim period results are not necessarily indicative of the results to be achieved for an entire year. These financial statements should be read in conjunction with the financial statements and notes to financial statements included in the Company’s financial statements as filed on Form 10-K for the fiscal year ended March 31, 2011.

Interim Unaudited Financial Statements

9 Months Ended

Dec. 31, 2011

Organization, Consolidation and Presentation Of Financial Statements [Abstract]

Basis of Accounting [Text Block]

Note 1. Interim Unaudited Financial Statements

XML 14 R2.htm IDEA: XBRL DOCUMENT

BALANCE SHEETS (USD $)	Dec. 31, 2011	Mar. 31, 2011
Current assets
Cash and cash equivalents	$ 215	$ 215
Total current assets	215	215
Fixed assets
Computer equipment	0	0
Less: accumulated depreciation	0	0
Net fixed assets	0	0
Total fixed assets	0	0
Total assets	215	215
Liabilities
Accounts payable and accrued liabilities	200	200
Due to related parties	0	0
Other payables	93,612	65,988
Total liabilities	93,812	66,188
Stockholders' equity(deficit)
Common stock	51	51
Additional paid-in capital	428,874	428,874
Accumulated deficit during the development stage	(522,522)	(494,898)
Total stockholders' equity(deficit)	(93,597)	(65,973)
Total liabilities and stockholders' equity(deficit)	$ 215	$ 215

XML 15 R6.htm IDEA: XBRL DOCUMENT

Statements of Stockholders' Equity (Deficit) (USD $)	Common Stock [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Total
Balance at Aug. 16, 2006
Common shares issued for cash	$ 157	$ 71,843		$ 72,000
Common shares issued for cash (in shares)	156,522
Net loss			(2,640)	(2,640)
Balance at Mar. 31, 2007	157	71,843	(2,640)	69,360
Balance (in shares) at Mar. 31, 2007	156,522
Net loss			(20,744)	(20,744)
Balance at Mar. 31, 2008	157	71,843	(23,384)	48,616
Balance(in shares) at Mar. 31, 2008	156,522
Common shares issued for cash	22	102,403		102,425
Common shares issued for cash (in shares)	22,266
Common shares issued for services, $4.6 per share on June 12, 2008	2	6,998		7,000
Common shares issued for services, $4.6 per share on June 12, 2008 (in shares)	1,522
Common shares issued for services at $11.5 per share on January 1, 2009	22	249,978		250,000
Common shares issued for services at $11.5 per share on January 1, 2009 (in shares)	21,739
Common shares repurchased and retired at $0.046 per share on March 11, 2009	(152)	(6,848)		(7,000)
Common shares repurchased and retired at $0.046 per share on March 11, 2009 (in shares)	(152,174)
Additional shares issued in the 1 for 46 share reverse stock split due to rounding up of fractional shares	21			0
Net loss			(349,607)	(349,607)
Balance at Mar. 31, 2009	51	424,374	(372,991)	51,434
Balance (in shares) at Mar. 31, 2009	49,896
Forgiveness of debt from related party		4,500		4,500
Net loss			(60,519)	(60,519)
Balance at Mar. 31, 2010	51	428,874	(433,510)	(4,585)
Balance (in shares) at Mar. 31, 2010	49,896
Net loss			(61,388)	(61,388)
Balance at Mar. 31, 2011	51	428,874	(494,898)	(65,973)
Balance (in shares) at Mar. 31, 2011	49,896
Net loss			(297)	(297)
Balance at Jun. 30, 2011	51	428,874	(495,195)	(66,270)
Balance (in shares) at Jun. 30, 2011	49,896
Net loss			(15,299)	(15,299)
Balance at Sep. 30, 2011	51	428,874	(510,494)	(81,569)
Balance (in shares) at Sep. 30, 2011	49,896
Net loss			(12,028)	(12,028)
Balance at Dec. 31, 2011	$ 51	$ 428,874	$ (522,522)	$ (93,597)
Balance (in shares) at Dec. 31, 2011	49,896

XML 16 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'

'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'

'+ "\n"+' '+ "\n"+'

'+ "\n"+'

'+raw+'

'+ "\n"+'

'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } } XML 17 R7.htm IDEA: XBRL DOCUMENT

Statement of Stockholders' Equity (Deficit) [Parenthetical] (USD $)	7 Months Ended	12 Months Ended
	Mar. 31, 2007	Mar. 31, 2009
Exercise price per share of stock issued for service one (in dollars per share)		$ 4.6
Exercise price per share of stock issued during period for cash (in dollars per share)	$ 0.46	$ 4.6
Exercise price per share of stock issued for service two (in dollars per share)		$ 11.5
Exercise price of common shares repurchased and retired (in dollars per share)		$ 0.046
Common shares, reverse stock split, conversion ratio		1 for 46 share

XML 18 R3.htm IDEA: XBRL DOCUMENT

STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended		64 Months Ended
STATEMENTS OF OPERATIONS (USD $)	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011
Revenues
Operating expenses
Officer salaries					50,000
Professional fees	11,528	1,675	27,124	9,831	129,713
Professional fees related party					306,700
Depreciation expense					2,936
General&administrative expenses	500		500		36,470
Total operating expenses	12,028	1,675	27,624	9,831	525,819
Loss from operation	(12,028)	(1,675)	(27,624)	(9,831)	(525,819)
Other income(expense)
Interest income					1,540
Cancellation of Debt				4,600	4,600
Loss on disposal of fixed assets					(1,516)
Impairment expense					(1,327)
Total other income(expense)			0	4,600	3,297
Loss before income taxes	(12,028)	(1,675)	(27,624)	(5,231)	(522,522)
Provision(benefit)for income Taxes			0	0	0
Net loss	$ (12,028)	$ (1,675)	$ (27,624)	$ (5,231)	$ (522,522)
Earnings(loss) per common share Common shares outstanding (in dollars per share)	$ (0.24)	$ (0.03)	$ (0.55)	$ (0.10)
Basic and fully diluted weighted average Common shares outstanding (after effect of 1 for 46 share reverse stock split occurring June 29, 2010) (in shares)	49,896	49,896	49,896	49,896

XML 19 R1.htm IDEA: XBRL DOCUMENT

DOCUMENT AND ENTITY INFORMATION	9 Months Ended
DOCUMENT AND ENTITY INFORMATION	Dec. 31, 2011	Feb. 13, 2012
Entity Registrant Name	China Domestica Bio-technology Holdings, Inc.
Entity Central Index Key	0001380706
Current Fiscal Year End Date	--03-31
Entity Filer Category	Smaller Reporting Company
Trading Symbol	cdbh
Entity Common Stock, Shares Outstanding		49,899
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Dec. 31, 2011
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2012

XML 20 R4.htm IDEA: XBRL DOCUMENT

STATEMENTS OF OPERATIONS [Parenthetical]	9 Months Ended	12 Months Ended
STATEMENTS OF OPERATIONS [Parenthetical]	Dec. 31, 2010	Mar. 31, 2009
Common shares, reverse stock split, conversion ratio	1 for 46 share	1 for 46 share

XML 21 R12.htm IDEA: XBRL DOCUMENT

Subsequent Events

9 Months Ended

Dec. 31, 2011

Subsequent Events [Abstract]

Subsequent Events [Text Block]

Note 5. Subsequent Events

XML 22 R11.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

9 Months Ended

Dec. 31, 2011

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

Note 4. Commitments and Contingencies

There is no commitment or contingencies to disclose during the nine-months ended December 31, 2011

- Definition

The entire disclosure for commitments and contingencies.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 450

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6952336&loc=d3e14435-108349

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 460

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name FASB Interpretation (FIN)

-Number 14

-Paragraph 3

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 440

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 5

-Paragraph 9, 10, 11, 12

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.25)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 825

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621

+ Details

XML 23 R5.htm IDEA: XBRL DOCUMENT

Statement of Cash Flows (USD $)	3 Months Ended		9 Months Ended		64 Months Ended
Statement of Cash Flows (USD $)	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011	Dec. 31, 2010	Dec. 31, 2011
Cash Flows Provided By (Used In) Operating Activities
Net income (loss)	$ (12,028)	$ (1,675)	$ (27,624)	$ (5,231)	$ (522,522)
Adjustments to reconcile net income (loss) to net cash provided from (used by) operating activities:
Common stock issued for services					257,000
Cancellation of Debt				(4,600)	(4,600)
Depreciation and amortization					2,936
Impairment of fixed assets					1,327
Loss on disposal of fixed assets					1,516
Changes in operating assets and liabilities:
Prepaid officer's salaries					0
Increase (decrease) in accounts payable	12,028	1,675	27,624	9,831	66,188
Net cash provided by (used in) operating activities	0	0	0	0	(198,155)
Cash Flows Provided By (Used In) Investing Activities
Purchase of fixed assets	0	0	0	0	(7,179)
Sale of fixed assets					1,400
Net cash provided by (used in) investing activities	0	0	0	0	(5,779)
Cash Flows Provided By (Used In) Financing Activities
Proceeds from loan by related party					9,100
Common stock purchased and retired	0	0	0	0	(7,000)
Issuance of common stock for cash					174,425
Net cash provided by (used in) financing activities	0	0	0	0	176,525
Net increase (decrease) in cash and cash equivalents					0
Cash and cash equivalents, beginning of period	215	215	215	215	215
Cash and cash equivalents, end of period	215	215	215	215	215
Supplemental disclosure of Cash Flow Information
Interest paid	0	0	0	0	0
Income taxes paid	0	0	0	0	0
Schedule of Non Cash investing and financing activities
Common stock issued for services					257,000
Cancellation of Debt				4,600	4,600
Impairment of fixed assets					1,327
Loss on disposal of fixed assets					1,516
Forgiveness of debt from related party					$ 4,500

XML 24 R10.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

9 Months Ended

Dec. 31, 2011

Accounting Policies [Abstract]

Significant Accounting Policies [Text Block]

Note 3. Summary of Significant Accounting Policies

Development Stage Company

Revenue Recognition

Use of Estimates

Recent Accounting Pronouncements

- Definition

The entire disclosure for all significant accounting policies of the reporting entity.

+ References+ Details

ZIP 25 0001144204-12-010109-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-12-010109-xbrl.zip M4$L#!!0````(`%=V54"3/J]7*QP``*4K`0`1`!P`8V1B:"TR,#$Q,3(S,2YX M;6Q55`D``Y7U0T^5]4-/=7@+``$$)0X```0Y`0``[%UI<^,VMOT\4S7_`<]O M*I-460NUR[U,N;TD?NFV/;8[RZ<43$(2IBE2`4C;RJ]_]X*+2(F41(F4Z&Y5 M99%)`/?@XMP%"\FW_WX9F^2)"DPNV:-PJ9B2AG9,&G6M0>K]DWKW MI-T@MY]F3?WBB]2JS5!8PLU&`4@:G10D6N["VB?--&'U4!CY0"4T#E>5V$95 M"P;@Y5&8_`3_2V#`+7EBEAO M=:5X!8--!-/1BE+!]6M4Z,(V66U`=:?"7B8FM:ACB^DE_!TT)-@@M85.#>Z& M$)FS1)22`T5BH^XDCGK;&_6PJ&Z[EB.F\;*2Z=6A_53S;T(]3:O4M4I3"ZNY M0H"_2:OGWTVH:#">7`=N)!1G+_HHN3S>2:C`K20JWKV$2A;ENDRNHVXE M5)%<3ZX`-Y**.Q.14A[N)%1P965(Z22L,Z#R48VA?R.]2H4Z3GHUN"GXH^LP M&:F&')>)==2=!%DOYA*S_.UCQ%?HQN,H5E;GS&)#"F&(?:D":57K6@/:!H?W MM[?H9TZD\B!W;$"4WSGQ;6FY=ZI-A#UAPN&`..('50/8CW='DH\G9GAMI*P/ M\54""-47:1S5%`YTRV>VY;`7A]PSW4&?[3GEO_E>6??OA54@0#`G:FZ$ESB!EZ$X"*(ZG6\DP%+SJY^/GI?!__:[-6[ M]<[;VGQE3TIM08PO!?3";2,F&)RM<,[!B<%5=#>5>A_&&&).;?'^WR(],&9U MNI5Z$T@QJS.[.P,S$QU<\16W0I67OU]$]-A[+7H$G;2RZK&W0SW^<>]`RYB* M7/SI0N_.[/'$MN!/>?K"Y1]WS*'<8L8%%1;DDO(3&S\RL4OEAWIE0T3I7?,N M&B`<`BG7N>/A(@:',EX.['NXDZ7].WH?%$ONZ-M:HAP?6&T1V5=,E?YK,;G> M!GKL[U"/*TP._AS;UKUCZU^^6FM;Z.-.#>V5$^3@DP]469,JIX;!,56EYBWE MQI5U1B?97RYBE_3T0)R2.5G\MP;R?78]:?8=Z//CJTOCJ5TZ5@Z_>EZ\N M'7&:GQ1QSIG^FGPUZ`35DE6/6J,P/?9?JQXWX6.!>HP[,NUKUJ.VNX"@'7*' MLN0.Y:/*J?SC9O`JC,[;IW52=#*[FU-8K%?^S[7*K9$Y;FF;<:M3:=8+3"]F M>CRXH=*XH;)2Y9Y-7IO)=3?08W]7>CR87)E,KH14"2+1P4+UR'W=6=[:[NCP3E/14>T\G"H=U"=7((?GL-?J4:[$/P^R:'_1#\ M]A/\=DJ"\CZ?$=/)PB'70G5R"'Y[#7ZE&NQ#\/LFA_T0_/83_'9)@A*?[8PM M!2^<&BY4)X?@M\_@5Z[!/@2_;W+8#\%O+\%O)R0(CY.]GN`7/S55B&&4_F&/ M.9T4>/1@X0SY(2'8:T)0Z.'XK(-]2`B^R6$_)`3[20AV08)7\&C,O$XZ12<$ M:S_F<@A^A1M`>0;[$/R^R6$_!+^]!;\=D*#T#ZG-ZZ3PV?#:#YP=@E_A!E"> MP3X$OV]RV`_!;V_!;W?+G@='OV]'OXOUW,,SK:5S]"4:]H.CWY>C+YP$6J=R MZ@[QU%/G5QLT=\N$PADV:_`G4/;[2-%K_+@,?AIF M0\D+]?'B.;/L,;>2FEU70;$F:G'T\QW',;LPE>W&ANVMP?C)A6+1'1MRZ0C@ MPC4=,^*/^!U^@R/UL?RS$<@GY_:828?KE'S@=L5A^LBR37LX)3_9)G[P2AZ3 M*TNOOJVE"5,09S?/`*6@YI5EL)>?V70]*%&;26TJ%'2FOH#C7'*I4_-W1L6% M]UCT>K(JWMZ!)RBMJ;E.77*3B3.X/K3%FEVZ'U,3*I$[-K&%`XHDZ'&I-8WV M,-9N*/-!4-3\_73\:)OK2<,/K7@-QRK/C\TLE_/L^\9UT(%@A40YB\^($V2E M*N-["&(PG4-?Y;NC^M'[5K_7[\?&<(G($%WP_:Z'Z63-0=3JE?]X8J)UPP9/ MX8J!5R]-FMRSA18'T`7F-1FKO0#R5OG73)2;A;,XYEA3"X(\4GIE+N&:7$_8 M?YIQ(0O-I`A"]F<0@VQ($A0VH\2$LP@J1Z>6@?_#]..)FBKS<,ZH$%.@PB_4 M=).5N?CJOAD%,:+$^=?0VF]KF83F#3/44+EAAB=]RPPS%$';@UE+,?UF!U.]+&`BM_/0 M1D>+:B/2^&9"U^QU+]KK-*&1^4U>.6Q;BP2VN>:WD+U6K]>6G;),&*F3@R9: MC5ZOVXJXL95"<\6XEL:VQ'C.GIAI3W#^=._0(8-9,Q,3P24[9P-<805'[8Y= MY8K.70&YS'R-//3<;_7Z$0O;'M1.^[@>LQL-^*>P/JJ1'=FFP83T%MAS&)<* MQ(%N;EO.E+EIXWZ0 MEY0ID<<'ET_Q.HUN4=:VQ>-Z>V'KMD^FAJCVQ=:V^PTM/: MG7[A&%X+6[=[1&2IHB$$@WO=-_*2LG6+`_I[BL+;G3%?SI2YA6496\',%EWQC/!.YF,.`ZW,*18Y:DZAQI$J"$C^PL-9MZ/;K7 MG"0FAN-6V`,FI2++)4O9K)O_:/?2!:Q.-Z*3^>:SRY[_T/72;<)>4\M3]OSW MZI;V6VLW>L5U?`4/NUJCE:?PC*S3&OVNUEP!`(_%+MR);.PG&V1&),UZIXL& ML%(80(KLB4T$-**LXW2,)X3_\GY[1S,8_KYFR=OW&?$U^LW(BO2:@F/C]R.S MF*`F%C'&W%*'OQW^Q"Y>T,*3=^>R$+D=]1\KA&T-+`O)=PHL*^TZK>Z&Z&XF M^$P#)!C^S;Q=\$+[&TC?W`GG(3V3&V[4HVXX_\ZOLX^VW)Y^E13^S41L!"$+!RLI)-P20A8B5M*8F*L:5F!(H^.6&#)2 MLI+*R10<5]83DPY.;[P"5W@*LK-#:T4"QRXLQ$5PYS2V&8CLON>+"<&Y=JV[#B7UT]VUN'(2CFYH5G[ M.&X14+(F6XWH&:CU`,T\S:6PQRB86R[4\%V1;:8N`62#4O:HD4P!O-Z(!_&M5R38)Q=>JDVT2 MG*]5)]D3KO@R]&[U`O5]%_P!YL$#OKT[J,]W94%$3C#6#H-YP\@XPAF17#-G M14I_^?O%VL?YZLT6_U.O5N(X").Q16%=E6@ M[]3;T:EACG(+T%*.8+=($+<1NT42EM_0K#J%HS6CCYCE*+<(2N0'5E%BW:-* M\3E0?E*+\,`Y0UWO=(S6;O3SM-5"3YCD#7;#.46._SBD!J`*1ZM1[9Z5TA=FN(2^-5.L3H MF>FB(2XUN'2(44KM5HMK0VRWLT%4R\J_,CX#5]NE=+/949>BQ>\8-"69]_:V MBX M;@:J."CW5RKP-8GRTA;W3#QQ'89`G)F4CW.)U8UV-W;T+A.`^74CP2@^^^[] M_\JZ%6Q"N9'C'DI\`6FIN!78YEYGD_/IE97RF67:#;XO3+[I67Z73, M+N!E-(NYM]MD0PC).;[T[%;8^.I8X\/TLV3&E16>=CC5'?Z4_DJ<+$92CTT) MUI2:)]@-5^_W`S:+">T=[*;[\GL!F_G,1[^GM=M;HP;KPY4%^6"?ZG^Z7#!H M`*HXTUL3`BR$6EQS4"^'R=/2UI>:)]@-+6T_8#>TM#)HMN1@,UI:5^OVMX9U4[6MIWF!>6J*;A4GV'9NX0A]!WAXNO*2^9W#+ ME"!=6A[@MDP!B@6W99*!BYK2(\M+V6%&+&?V@WJX#=X+4/,'F&[@+!IMOX-ZI9DL.-K-]==J-U;/G5:"37]#O?91D M?L4KY[7F+*+G5O^\XZ;X0H,\S3_:;C:!&Y]?W53@AF:85P]W('";/8Q4F>&) MYORI$VLZL]AM#T!O*'9C&N79VYV)S>%<=8)DE;Q@1L,,K8B]PVC[LY,5D.H- M^1.SF)3>\WKSDZ%<'A!LAP$KI07W6_%+6PHYN^/I'W#;.'+5=^9SIL)D<[4 M9.^.QA0$6B>D/GEY0P90Y81H]8E#'#Z&`&JQ9P(`J'7L73@F$N+&X,W1=T/G M#;;CXH]KVV%$JY+OZ'CRYG^U3OV-\@U\3#Y;U#4X[O7[`9*:)#RD)@FV4'.# MMFH3_/6/O^>&+X23<^L$]5JA)A]"59,-'$_>PTB%;FF;W,#Q(H_4Q/2;R!%C M#K$'Y.RGJ^M3+^X>KLE'RXNJD\7)S]='WS\>;'W\E/-Q_/KZY_O#\F M5]=G5?*]`PUZG>@U&O4W9][W\\(KVIL?")78+HRM]]G3IG9,<)"/";4,@O7E M3-M0T`X?/E$%=,@)R,"TGZ4Z!H#E+6XQ4H')@C.2Q/N4)F$69#I)0D;T"6K8 M#GEDS"+^4$=Y$/]C.<'C@FW5.OVA%OXUAV``FJE0X4,U.KJ(R@"&,;>6WFX MI9NN`4-`39-0X[^N]\"P)-^C@KE:(R&V94ZQ)0NKF40PW17XGOIHA1_(\XA# MXU0`4.B`E%1,B6.3B5K8A`8$&YA,=Q2\04C2X&E8;!_O^+I?K6^(B*ZYH.Q` MN\Y(,!9H-T6MU:_!%LZ8P,.FL4%%%0%9L#$U8J!\?YP-Y,=,^1'.3O!8A/`* M4/!SPE`6]=3TQH>^B]!P0:A_MLXGAU4?F?+>6)E/]1`W0Z MAB[HU*.QHC"PR\#S%P:!`;/'W($*,+:F,[+=X2C"62AN`8\^0L2&(B.U@'X.AV:FC(JH1/!BDB4/A@0M MF`:V!9,%I5;0UW]=R_LBJQJ3N!7-6HVT,J,!X$J4$V5%Q/@"QZ=UW\CDBA2O MFSAZ%H%(.@8"5WX.C6^@OL^H.NS;WB'?N>7]',,!;`"%.H M[!`3SX:#4=`)N/T72+PG,#:.5BQ^Z@^FHVV8]CNHT/HH^U"?N*"6U!OTU,!$GG,+9>A45$R MM/WT$CE4):=I8?"9@38=;+884257$&F%`4U%)<-O+X8R MU;#%0+%PS?"^0P,.-GCE(I$`7O>-'KLTW``08P?`>(H7\`1?#XTBQ$ M5PG0QK"55U7Q0+KX'C^.OAX&SV\?/98+#:.N$L*[!7PDSC,SH;Y'G[R#>:FL M#/>JQBK"80Q\QK!L8AZFMKL)OH1K[(Z5PI`\*L3/[$09T2+?F_5CF)9AX9`/ M"1JO1GH;_CH-PC0@40$XL#?)V!=$@#V,,(5YKZ1$HH"K<,&\4`@+7@P%B2,P M)*A+@1`^:2!K&`(R'<\18Z)_G`3&,S1BFYXMR\:99B+\OH$W+WY"1_149?)1^83EVT M)J+>]@B_#(8V!%"=V004YW/JW4KH`\S(YQ,A3!IL@J$<1M:=0(6!ZT!F3R!^ M0.^4#?D]"=M+5(/*M8/L/9ZM/]FF-W]@!)&B0_+]J?0GK3.EC6$R`:54#`;E M#5P3V&(,QU[P/-4=5TV`O71_3*?D"1DZ@&'#]N7,54/IU"%#<6JF/IOF_$L& M4_;C8/3\:7,XC#AP4`>W#\#!H'3LMI4'B(CG]HCW@<`@SE023N=BR,)G`7' MC-.(J$#ZWT`,UV`,-L`G6GY&^UJ[`5*_>/CY:U-P%$,F9'GG$CX@` M'4&4`S&V(EHD+4;_`[>`F,AC-@`C1CY;:$7`<"Y'6`%)^X@V"3:MV(V%)R:U M$)COJS!XS]+$<+D,>@(`=5PK.P5!F/KCHL'L@XO'\_G^<7R10G+(C=`[@D0J MG#EO^R^9H#T:;DRFYZ1?@>7@\THX=[ACN@T.!757UNYN;3.WW@*2G]-%N>T[ MV0066(HTN."*E,*E.'#=2F7)2?5G#'X,$S[D?!!1$EJ.(E#Y(S5LZ`;U/+A* MEX0W)G]A2[Y0B'2X383H4S%MC\U;Y9I$;@PL8%M@%>^$2PS"$(TC< M'2AB0E6AHDP-0BY&5X[;\>1[4`6#F1_..94TP693X4C0FB7!&+<8\[93U#X. M$Q6E/5OWUAEFZ[^Z;>)R#8)<#0$)`0R%C]5R5FH4GY\'X]VQ=6RVOJ,69(4I.J^,OA^/"@$__ MY,7:<,=D$4[@DE2A<$9NJ,\01RHI]:C<>B$)UM52M<&AVR)P6W8L$2XK$_.) M@CJ;FY,*VX+?NJ?\LO8]SS0RMET0,1CTV^R)FJ[:HQ5*4S@A4UO_4<-33XI3 M8:RW-!,_W@8)+?=V7/&H6>`CL,)YZ#YVOT>2L(#3JI((6#5& M,;A?W9$$+].Q;#7I\+JM.!#MM%I5]\:)1;TL'@98L0^21*!L;(B?\H%9&`0Y M?(616FDI!6?:N.@7X"(>L*_L[,JG-/\H9QWWUK["N!UW16$4#[>H8ZF#_[>? MR>,^CN\/!9L_10+S!U^2MQP]VW-6R8_A;V?[YS9FN\3)RY#^QHP=C_@19Y=& MN#@MY]\>DDC'K!]Z/UOR=;;$MYUH[4[\4V?SL'(`OIN/;/]_>U?4 MVR8,A/]*Q'O`$!I(I$2JEFF:IG935?5UTAIK1BC/=&89#$%6RK92DNL%IM?)GK7[F1>ID7F,3CQM/ MH6A-1V*4?0VA@HB]?'W(FFLUEJ5SUB>,7O)^)#]V/6L/V+6D9."%5K^!X/ M:E2<\GPPH.ND+G31/%LENBXC8*"=5L<9-C"9#+3=1I>.]:I MW'7B;$T='Z'N(6[>@G3+O:@*MTP7>WQM,$>S/%"=JBQ<$J@50/VKY\S1G77- M^R/,<7#H%QQ40EG63^3!Q$@8;[#1JDS$\QXBA7S*6:V)0`,Y_["0[T]9MC)] M;ZU$5@_\6%T+(1HGVK@>CZZ:L/$T6K4T:!"&_HV!2?%S1N6^*FVZ<)MC!_L$ M&Q(06Y(""#ZE@-2MQ27S<$Q6`S]B[8VV*C?!>>OU^KC*HG5I$:2B&QD:[Z'E M'I!)L@1)FS1,%=(MBZU=P2(EH(B'0/]O(/X'W7O[`T<4_2E^U^/<-+H=3^K8P_\U?\2%OJ@1D/$[-U+13@/-(C.C*+DN,OFVVRS M\/;Y3^@MF7C:KKJP%K8?BY):"'Z2R]UIH?-0D';_EFVQ^:GZ4K5GSR1T_ M92=?3[>WK.;I5?4MV?(D"Q9Y%_0HPZE4.(0Z'^V>7U"["^]EOW^;!\'A/?Q$[)T`,))"A*`%@7G-]/F=K!(?B*':R3L^(;CT_8$PVB=H;.X M1LG"8^]K)>IX2SYVJ:(/P5`3L:382B2!2&T2G5JBWJ/MQPKA6.*4[3%(QV%2 MME.>*_MO32]-QF`RQD4PJF?H,1425`;9Z;`WU)*[[K$7*W7=!M#]&ZWMYX/T M.^U-,M!'6G=:J@5%J7^U579IU][X;]B[_#-;U,0AIVBQ[>4KG3RGY;4WIW&5 MI?6L_*6K.47^@O"ZIQ:I;O]G&'=F(R_8D<:=@H*TO;>+X]&^QW_1X5]02P,$ M%`````@`5W950!CF+$FE!@``9DT``!4`'`!C9&)H+3(P,3$Q,C,Q7V-A;"YX M;6Q55`D``Y7U0T^5]4-/=7@+``$$)0X```0Y`0``[5QM<]HX$/[A$#K,I(5)TEZ_=82]@*:RY$HV+_WU)]FF`?R>-\N]?`IQ=J7= MYUFO=B6%L[=KEQA+X`(S>MZRCCHM`ZC-'$SGYZU/-T/S3>OM/[__=O:':7YY M=W5I#)@=N$!]XX.4F6%PC!7V%\;%#_,SAA5P@U'C)@#AH,TK8PA3'B"^,;K6 M*Z/;L;I&Y^2T\_?I7\?&Y,/M4)^CZ0WKR#+-!Y^L^SICLDXT&<'TVQ0),"02 M5)RW%K[OG;;;J]7J:#WEY(CQ>;O;Z1RWMX*M2/)T+?">].IX*VNUOWRXO+87 MX"(34^$C:M]JJ6'2]*R3DY-V^%<`K'V@CIH\>JI&?[CYU?0OS@BS]^8DBB_& M]U&+IPQ)F2$Q#9D)A#E'R&LK--M`?+%]$N)K=JR8H)?QXZ\](<`7_8!S:=MV M`H*F0,)IOZ;+M9_(B+M$#V_CSC?R+SR&9$`2!OYV5W\<1@W`%^ MWNK*W!L(:23SE`&(M(P5X/G"EWFY!AHC#POC3`\BLA@XH$E/I"\QFF(B\POD MP;TK54,TV#8+9/!.T`9-"1[''/VI%T=C?P&\TFN6I:$_.YF^QM2\UHN::Y_9 MWQ:,2-N$6N']30XK*<(U%&?,=1D-32FLPPY%:PZ?;+`3=5?"23VS;\]Q<&3' M!&%G1/O(PSXB.^;GK:7%RHTAK`P0>B;G`2R!,$^UB[)OG,,%]8%['`L8P`S; MV)`&X7(S"+@L^@\U\A;:^P_>F!!X"""+%PFSYOI>UHB5UHQ"57V6]%S7 M#MG>*P4J).>F^9DF63J1G;4/=K<>;JMN1&WFPAUWY6+EI]B`BZ=Z^IK;`RY] MHO.+M0=4Y#;F2=D:>H29S)$RQN2*J6P(Z<@S.4V\YEI*8>*>K3UM3BW5T1[R$UWKVR0/P.-@X M@M1EW,<_HL_1EAFHSQ\A=\^IY`BZ4U@9D9C0-WH1^EZNVQP19:WC8HJ%K]Q> M0NQV#I%%FDTAL!"!F#BKHQ=S/QV,2JM+)DK5-CO2NC"4="!1*23)+"X3:FD1 M/S+*]OTJ?I.R=9[>_A%=@O!5S1Y9,E+=NWR28WZF2LWQ54C%891E^_[0-6E& M'=17]TM(!-5X-H!I&NQ9DDU!.]-3/?<%WR-,56H:TP$67GQ[9#PK/%3/UVL* M6251T+-8#:T;N1["7+W4_07B\]S.+4.A:61E^5U<@=:R9-XN_T/I>Y]1Z6@@ M?8T7?4;%.Y@Q#I'<#5J#N%C+(DVZ@RGBFY%$3TB0;*DI@24A3"56K<>;M>:` M>0)`,PNTW5JN`=O!-4"5\SKKN0+*[K54B[$O5W?23#,Z6?`](ONEH_\13P?4 MA<4A82LQH@[F8/MW/"A(CO,49P;)6>N(?67%A+,EEKZ\VWP2X(SHSW37LWV\ M++KP5V&0Y[>[[-M=D99$%MYW^[G!>T3,[]'QU5*0_F\VN>__&E7=_7[N$/7D M\>XMX_.>C#8DEMNDR3O'J*O_YX#4];#HYXA..,A(=(IWS@M5&\]I,3A;6G4[ M"4E:?O!O%I5X/=3]!8E-P+-E5K/]@)$0@2KFQK/P4IQTD_NSGUW+)7_X#4$L#!!0````(`%=V54#PL?)9\0X``%?E M```5`!P`8V1B:"TR,#$Q,3(S,5]D968N>&UL550)``.5]4-/E?5#3W5X"P`! M!"4.```$.0$``.U=6W/B.!9^GJW:_\"F7X<0D^E+4MT[12>AB]KNA$K2/;-/ M+F,+T+:16=F09'[]2KZ``4N6;!F)+$^=-KJ<[WRZ'!T=21]_?Y[YK27`(0S0 MIQ/K].RD!9`;>!!-/IU\?^RW/YS\_L^__^WC/]KM/S_??VU=!^YB!E#4^D;2 MC"'P6D\PFK9N_FK_@.`)X%:`6H\+$'K.RZ^M/ACAA8-?6EWKUU;WS.JVSBXN MS]Y?OCUO#;^MB_J15-^R3JUV6WEEW7>,RLZ2RGR(?HZ<$+2()E#XZ60:1?/+ M3N?IZ>GT>83]TP!/.MVSL_-.EO`D27GY',*-U$_G65JK\^>WKP_N%,R<-D1A MY"!WG8L64Y3/NKBXZ,2_DJ0AO`SC_%\#UXEB;DKE:C%3T/^ULV1M^JEM==OG MUNESZ*WD(FF\:%5-OH"WG>3'$Z*N7SXZV,6!#^[!N)7^^?U^L)L/HJCCP5DG M3=-Q?)]4186XC%[FX--)"&=S'V3?IAB,F1@S`:CH;ZG0;VAIG3KBD+\!H@VA M[8&QL_`CA<+MEJU*U&#F0-2,I$G1]02-RVC/P&P$L$HI-\JM)>*42(/=Q0BT M5]`5"EI4>BUQ41#UE/:;M,!$J$RBLM)=;S0E15B6U4W&C#?9:-I#W@V*8/0R M0.,`S^*1ZJ2U#8^*Y4*`P,1Q,0`_3Q&(.C$^;CEUA7R(G`C0TN_&?8C(&`P= M?QB$D!9^Y3MA&$\I,N(*EJA0\`&9BV>@HHQI9H7BW)'V'9,3#AU,ODQ!!%W' MKR@?JS2%`E\YX;3O!T_A`'D0`S>J*.IN.0J%?)@2^-/`]XAID&I#_< M$77@JV`V)S_1H60):K4%N3I4@HL"]^=&Q==@#%T8J6A!@H4G<,AD#%'<5[\2 MV3=0@><(((\.!LE76D_=X8O6^/+&"6TKDW5-:@]O2DWFT*R\=#J5,E+'.)@)J"RK,B@1MQ5@TD@_ MG9`U?.$PLZUQ!D$<)*^7)/LZOZ9LD*S-97&3;*T@*6]^#"0PC[*#HUID534:LI/9O#;%1M*"N-C%Q1,^T;FE2 M^Q61'#L^L:S!\[_`"U?O6VGMMP>D^%W9,\UW]Z[YJP6F!G(?AL0^_C=P\`WR MK@D8AO)9R>UW!Z%_CO@9!>>:&G\?^F0)1F29!)C?]#=2VN\/0O'%DF'B9C0*?H>V--/:'@]#SMLR9AM_J&M*#V2Q`\>H\=CR$=XN(;H-0 M(?GC.R>C?7$07`@!R0AZMW>",I_%(RF6044^B6V='836MV7.%/Q^[PKN$3$\ M*DK?=UB-?2.-;37DS5"LXAVA,QU_T-:(AX"L*#R^[5*8UK8:A&0X*`:P73YJ)H&:M.`VKU+9U&&M7CO@K M"A@+V(^=3<]_0YL!@IN#QVV!X[;`Z]D6Z(4AB,+>B#J4W(A#U&;"IC8"%`XZ M3,'5N\OJJC]U;PBSL)6^,<>_&!F["N81L2N[0:Y^&B700Q[]A^Y&+QV?B!KV MHBL'XQ>R\/OA^`O>:":47[.SF4E#,6NBD`QB<0.A:&?2[(F69&5;=)/&M"$. MY@!'+T/?22(K2+.9T\'Z%H@,<2+9-;NM14<\02@FD??-<:=D3L4O>7&_X"#D M&9WL3)K=W*($%-/'A672>.>2I=7")R:1=PWF&)"%"Y6%_.V#6.'(Z\T"',&_ MXN],I?"&2D55:';'UVL/"I5@4I?G*:7B.*W9TU^/YA)@ZO=\ZUHZMP%R!8V= M=5+=^P(UNV(!&O4[P76)*:5#]\Z!W-(MOV5@0NO_"IT1](G.@(@#HR#U(6PB ME(AO$A]D?@P69'$X=%ZH=XQ.AZZ+%\#+R2ZP*A,O1?<&!(L3IOD@`\P@`_-Z M`1Z#>Q!;/D,'B_'(SJ1[RT*.-CX.DPRY^#2(5%]CY+`MO,!,P%=B;;,C]V3PR%223EXJU*O>Q;26U+=Y`? M5\D,OWH!"(.F_)[GP:3RH0.]`;IRYC!R_)S4/!.N-+-MZ8X%K$"9&"R3+()K ML`1^$"^KR:@Q`3RJ06I>M+NZPQ\KL%@,PZ0),6]^(4^*H[*L=OPC^& MBAU#Q5Y/J-@]F<;0@KMZS9(<4'A83F23++?T:A4TN7F>`Q0*>;B9>30'B,G0 MP<-@DLUT-R:V'IF$Z.4K1,[TXB0V-07)-<>!<37-(*<8A4'+UB$.QB`,X^K[ M@#M6;2?5'`!6@8X"!&J&L-W[@.B7G?IR3O$B:[0TC^8H+@F-BT`Q:73*AZ?D M0U+2/:D_GBZ0CM.QG[3'$95Q4(H@*#^++L".I(5^E=^7&M!:MUA4W4X MV42A_@1[=5IN`Q1L2IG"$UCUE.;5'615@3(A3.I/R%$9*W4%45?3- M@6*2$^<+P4^'VSMT#<-Y>I3X;EP:',K-ISMZJD[_*`5FTB(JEFHPFSL0TQY] M-77PA&N_%6?0'4Q5AR\V(I,61TR$5:P&W5%7,LY2+@B3&%I;GGT"^"I`1.(% M$7I]@?AG,`YP>GOUH_,,PIMGTC@)!(@<_!+K@4;[DYQ$F7Z,5\#":*S60XH! M:U@-)JVV5Q#2?O`9(,).>1O9R:$_I$R6WT(()BV];T$DM.C>2*<_3DQB--X6 MW*05]HV#$>FXX1#@^#J[STX(W1[RKJ&_B-:A#@5\E.34'\,ESI``%#6+:L8R M[0\`)U-246])1MX)N%U0:'?C-(!P^Y;!!T-K]=C>!7?VY=4[:7X#M(H^Z+D17(I> MEB)?F.88\ZH$,EUY\O`-LAVK^5HU[RM7TKF(*]:H"/6>]Y]%$B(2TFM%R"SB M0A]L"/P8J.O(352G.5)>94-I2#TFS0N#,%S02)GTL5TR2/[A8/IZ7-@/\`/` M2^B"\`Y?^0[D&J!2Y>B^H+4A6AD;<)*:,3823.^>]GY(8V,WJ=/N[P"'WGWN M_794<9V\QC@TO3OI^V6:J0*3HJ(:"@_5NQ^_7YY+56%8=-+&.C2'.;U*2,"@ M%R]$][F'/1MA4GHQ*3!J5_(A!F3D\LJC6,NRZCY+(4F**+.[(`U:X.^*NW7Q MJQ2?6WEU']9HB-`"E"99X^(>!R4N5>TG/-1ZXB10FV1V,R1/CG@I\J=S"M-] M;&0O#O42_":-`61H2DV9GDOT@4&59U3$"]%]#*4B8<7LR\$V:"XG/'! MB0?2`^[&E5@7+T7WN1*UM,OA-JFWB^M!R:"O^[B)4MKE8!_`E)^^!JQFRN<4 MIONPRUZF_!+\)C6'_/B5O^R)L:LBDDWW:9F*I)2/[T5`39K(4PND'^![,%]@ M=TK:\.KX2,EUYN69=1^C44NK$%R39NM\0UQOQ@J26Y97]V7)C759)EJ3QF!Q M]$JF8KNK^3(4E63+P39I9TS&$E$4M&IW]3K=U!I?LLC-)U_U(^Q=O>ZU^L') M!8!,&K@?%O-Y$AKO^-E9BP$:!WB6A%P(O,`D5H+=/9P+6R0@F=0CL^L^Z+,W MW-VK=3*[J_F"%`E-LW:I-M$8M)K)W=122LE&2KNK^5H3!:SL`#)I)4*OR2&X MUKXNY*W,K7AL$+O04JP,NZOYVMJ,"&.T+@3M_%9X!KWU9W&70%*&CYM\`&*5W&"UZ$4Y3O,:U$8 M2`PRK[@Y*]%86F\F"@6FM='D'E7HBAA2NVU**K>CHN(;,#+ M;N#[MF$B%;XD5Y1!\\E39M)P2!B&&\:E_+#S:?Y)+DD36503/(OY';J M2BG:2:OYB@9)6HK$-\X%4./5Y,.Y0+I0>)-ZQ<[]GSPFMM-J/@$K142![,9U MB<0]E+Q\GFPXQOM3M^`I_H6_VA'(K_D6X*R]!]RK,N04Q0:D[IUN@\CT_,.ST%L^L^L*FT\Z1XU+QK4+?SR'-36(;N MPY;J.T\*RJ3G`6/9U\'$7@]Y]R""N*"ME5D68J7H/CTI;26*PRIYR,!`7I,F M6IO8I!C=!R-EV:K#^1IQDU;DVO^5&TN8SXT4I]9];E%X%&6+GZGXHAD=Y^Y" M83@<*P<\*"E<]Q%$"085H5U[L`P82?]_7\>RS`E0V?%S7I/J7!@='^@Y1J:\ M^LB4XP,]YNS*'A_H.3[0HS\:Y3`>Z+EY)D,$#,$00Q=D+SNFDWEBW:]O8>8X M7"6+.91G>N1AJ=G8K4Q6?OW+VVZJ4YSF,"*%Y+'@J=D55M#C.%Y:R6(T7RG? M2(]+8*G9_A4A:_/!U$+_DQ!;`N4<0'Q+55R-;A[N_;VY`W'[2&(JV3HL<"Y\ M[-!*1X1M\I__`5!+`P04````"`!7=E5`85$R()P@``#;R0$`%0`<`&-D8F@M M,C`Q,3$R,S%?;&%B+GAM;%54"0`#E?5#3Y7U0T]U>`L``00E#@``!#D!``#M M7>MSW#:2_WQ7=?\#SK>UL:M&EN5DL[$OV2U9CRWMV9;*5K)[Y;I*421&XH9# MSI(<29.__O`@9TCB08"/!I2[+_9HIAOL!G_=`!H-]/=_?EPEZ![G19RE/SP[ M>OGJ&<)IF$5Q>OO#LQ^OSP^^>_;G/_W;OW[_[P<'?W_WZ3TZS<+-"JOCEZC5V_> MOOKCVS]\C:X^[)OZB3\>';T\.CB8_&&OOU4\[!5_6!*GO]P$!4:D)]+BAV=W M9;E^>WCX\/#P\O$F3UYF^>WAZU>OOCZL"9]QRK>/1=RB?OBZICTZ_/N']Y_# M.[P*#N*T*(,TW'/19F1\1V_>O#EDOQ+2(GY;,/[W61B4[-WTRH64%/2O@YKL M@'YU%?%JG5"YV7=W.5[* MA4CR_)#R'Z;X-BAQ1!_PW0%Y!G_`?U1?/T.4Z,=/%[M66`N;XG!3'-P&P9HW MD@0W.*F;>G8XBW1OJ/I'WS:E>T\?*XK8[8M!_QL/[=\<'U*W'!>%B_[CDGE;84);7N MS%8O,B_VGCR_)1E^+'$:45?(OZ6<&L?._2$=$&B;I-$L;#67T+$AR]N:AM'- M'='FZ.CH=>5_Z3<_U^/?<4I<0!F7VXMTF>4K-K8,BV^0AME*:]WU;G.#&0APZVA)..HO!Z<&/GY_]:3<#"-((<4;4 MX$1?:M[_^9X_?TJ%R`SK)MN!_K>C5U0]G#UJ+L6.I8J)VASG;?L(\K`6B7SL M4:>B.`PS,EE;EPW,FM0R*&Z9//9^B7N`0)^5N MAL7\PL&KHWIF5GW],QE<2TSEN@YN]IZSX084A"`VKQ2RBY<=`?K"2!S8\92R M0J!9#X`:NCUOWP%.RV(W>&T*J\$!)4.,S@?@3B&T$P0+T%"B M6,2%+9(+'+Z\S>X/(QQS$),/7>R2KW[FOOX3OHVIBT_+C\%*YF65I""XU0C: M!4`U&._I$"6$1^T,(D-@M@\2-6)[\3`O7D^(C>1!DT>>QT48)/^-@_PLC4Z) MOU>`5TD.AE^-P%TP5*2(TR)*3)9%$:+D;F`\F_!0:.Z#2Q/0O5B9UQN?QPG. M3\CS;K-<[XO;E,">N"NFPJ,Q,E33N73"$PD,ZW^E8!"]KQP)<^'T.@_HMN'G M[>HF$_J\$K]-`X;-KFC=EUS]CCB!&SB.E1$*@=+7W,2>_!W//%?-5JLL_5QF MX2^?[P+RABXW)=UWI8+H)ZXZ1NA9K%X)U>20<2'&MD"<$34XG>KTFS"GMHD8`AOR.8<@^`_NX&R>,DA$*F[`4W,2A]NW.A M[9@\*:)/.T\"E?MMTX#AK2M:]W7N?D>4P`WBQLH(A3GI:VZ"3OZ.Y_9QNT07 MS<)?3@ON];JB*IT+)W2\W)]>:FCO*(6&S$W*<3$W"!2-WB^3II8=&M!(R,E2K\0*#;!HU,\?UGMH1JIOB]J&"!32] M0?14DKM!LP`3-99%C#C(1KAN_6'Q3WRU[+'#!Z'Y"L M@(@L,ZA2-DY4/6E%UL*A-CAU M%N@&W\9I2C%'IJ5!\'-W$2ES$VB=?+J$'-0RYN]ZTWJ+R8 MLUA+[1:J&DQT<:L#!*`G#\-L0];F5\&6GFXG$R/R3;[!44,\@_6R12NP8X*5 M>L+`47&CBIU-[*L&4*,%'U;CTRBZ;B@:5(HF.N,"&J0<:0

H':O%[F*(47HV MRMM*7PUXSHQV.GDA+;,'VEVS[,.UDQ6IV4K4V0K4=@WG8+FI#(EX,!\>+::C M-;'!6MA)1G,6_G*7)1'."[HM4&Z-\IB53,#9RQKAQ<3>/3'BU.BX+//X9E.R ME1&9M9*9A2]9;X-U^XJE593;YQ%>QF%EO M75+83#=14"'YIG7(GE$MT$51D$6RPQPV8[D+2N,L0VU4]RH77:.%M\E*&ZG" MNUT*VKL@H?4-G":@C53FC%W"H-8$--U,X6.$S#*5@P$,F4<1.R42)%=!'%VD M)\$Z)L!N2*:+E/H:A@U M6D:\:20P.MR!F*-CFBI7*SX4<=7+.TR^VJM?3*V^K#32_UGUKXUVS> M2`L/9N;CY'0;;C4/LSK.(TTC*U_8R^HLPU2AB"[=M#XU4SJX&'N$"L)N&U/$ M3X\YJWJ>;+:8FI,N'U=K2W">X2(-LQ7>W51CL"NIX@#U`VJQN^#BE*A169Q(>T@1[@=*'?AQK`K#(R'0E*LBHY>USCM#`Z6:'F@P&6N"C8#L4YUB8C"J30Y_V[@DK. M]N]($*5Q>G[?2MJE5%K@`_M2($@.Y\M1,*+T=[?-1N*\;$G=SP-7ZKM']%Z( MM@X^.%A-CU:"(K=U\&0.)8R*>%MJ<7V'47![F[/M$!2LZ'$L>J,3FR-%<;FA M-5V668[6@KKA79#?$G5OMFW-Z4$6NH6!>968QJ8&#]V]=%@1W,3&6I7`C0P, M,PYH7(5UE>QK_RS_SD'*:?/V+M^33#%H!WGTW5$K>8]YQS!*G(W,1@ MBW@*Z>MEB3A_]A>7\3VNEK@:/];'">J_^M7H0JSBX`?T6SQUA,6='QBLS>^#U?H_@[8V MZF`+C!<`4@;2&Q@:3=<+F%J,P^"I3=#4<;#4*$CJ4614N5.6&<1%84QU6IF= MQG*-8[@NK8[OHKS/"B.[:U"[L;R6N&K;J_:XGE/".?:M;0U0*S;]&E$\U9!V M-UV>4&`GIB>B66E\$BC#F=_'+,W:@E2^P&#GL)\7U#1-5.D"J,FSL]6*[847 MFXI#M.*W0<2,^GDU)CE.*S'&6==,S$$&F5ARCXN2!C^Y1!3,VK2RBX6J*9VF5MB(3__J3(#=V<6II09-@E&#W(Q"Z8'X2,VHTYH M5FR2L`'^:VZ--_1;`]MG4[J.UNZ;Q'8`QZ"!.Z5K@ M,CV-BW554?%RV7MEN)X/-O[4`M*=$%:FKK7%CP1LBSVB]`\H@>">\>9$$2]%GR#^P\Y9>"FUT0GQ2 MR<$K52B]H;1RA=H5>A!#'1([]21F:ALK]3!`JMZO:X1'D28^"N,WC7 M.JSK[)P@G1:>$\5.,K+V3C=$KLMZ3ZEXAY=9CCG==?"(B[/',@^R/(K3(-]> ME'C%"DH13M)I"5/)("(\WU,=G%><&W_;"_"W)`]RI9Y-[RW*J=8TB9=.<3?GO:V&P9^Z@]_`G=6ERP_ MQ3NO/X8>TXB4U;#Z#J=X&?>/1R*'@[%$)K9P15"08!H>K&XF/,5+G.6FRNZ4Z-YS>#] MC=)E@UY@=$85U)2[;:7+>7?5EHD&]G$QF2O0S6TL: M"$H%M)3/X$G#`K7F\H$N9F6Z"0M8J4'!&?Y9D--+AXLKG'^^(_;Q+BCB\#B- M3N-D0R:9&E?0QPGJ'/K5Z&*DYD"$!3&>!6)<[/1*Q>?.5PQ7B+L.NKV/PJI< M`6V@OH*9_5&@;%,69<#O87Y.IC01F6H&><'8&(GC2)`A+KOF9`K*$4E$?\/Q M[1UIZYB\R>`6?]RL;G!^N:RN?6:]>[GOW'Y[FJ!1N-2DLF&GL_3&7J_E)DFV*.*4Z*'NI:#J)8TM!TLR-"*\7.*0;=P= ML8/NWWQ;>8$DMR?3'^F6=77VF#>%Z_*8C%FT5/3^[^O'%`D68O*!5G-)+'`+: M#GF1--^MC%>T&2(-?3K-T9)*EGIRJ<,DPTPK+VV:,6;$R+F[VNYRN8^&\479 M'2YC\K(UIT5L6X`;$ZW4$J^HKF\M)$->8]OA>:L!MV=(?B-:&OE#"#4=>A5[ M$VRYD`'V-R9=O^&9/O%QE85I/]-1]21+Z3=$@$]4#)7'L&H#,,7?3C5503$^ M>%4-\!@V8DV@?1N(->(JV7X2/?D@O9!-KA9DD;O3-)])4[,T_7&J7M_%9/9! MK(MHN29-D,<5;"K2U6\W.6(_UA,DGB`?R+K(Y2QFB`FWD^F'V"]DS8R=0SP) MBKOS)'LPN2Q7RP9<1T.K@':$HPR(<7AQQ'6P*IFQ*K#U$_JA)592,,`58,E: M(@-90M#_Z.WM]T%"O=H56UM=I&&.`UH0A_]O8#6#FH,M?3M,8?'<$T$C71RS M#XV6%HBWA>K&T/.Z.3^.F7O;`:!55$?`7JBT.@;SH/O'5$2V/Q_AZ-WV1S)) MN4AWEU,>[N0,1+MGR'0IOR/+*_]CP8_C%=483G=(P3G!KM_HZF\[D M9WD<<`GG63I,++*[>PQ-:=D]"(GI+^3GI^A@''1DF9%U<]V1:3<+A_Y,OPQI M9Z[KSF3713UG:_&;[8O&Y6W![NEO75/*N39MD\O6X# MD490W0JZS!%OQV%^[$AUZP@DT[3:MJ0;OD7%ZCC?=`A>A2S406`%S4%O+7,: M3J,JN6Y6DLVT$>A,=7/E)(>8A$7P1=H8VJLFO!C71VEZ%JDMCO,KQ.HBC_K/*O:R.#4]0Q-#<*C[W5YP/4*F6 M/>,EJ[XJ-.6VAJMA?7!M3C7<.@.YM?2[`(6IN#3\XS"D=XX55\&6GK"PLOPN MKV/3%U4QM/V:$56VG`!@@W-&03>`/6+`ZVU2;" MTTA,K7]AX#M(Y[ MB''$[A.BU]5<+@:>ANF`=33SU7>^-6=/[[G M/$Z#-)PH3*-KS`=?I%?6TB?M&GLB81H[Y7O#-#+UO31@`X0;&K()O-TL23[A MA*X[KP(RT5&45#-B<[;HD"B@7V54#(AQ."IE-E81EKZ<9$%*A\:\4FA-.?V9 MAZN0I9MX*V$%'\,\S_)/>%U%3';WK-`42X/8I8;92?B[FQR_B/;^51>-]K)KQ M]A865?C)]O*1IW'EBL(Z8WG2=%AW!/N`]XV[J.KK33(J7S3(3@%O4-NL MUPF[LRI(ZCNK+E(RY5RQ6^U,+E,S;`'V7C5CM82]\0;G_EXRU&#V(M(_D8)1 M7(1)5FQRW+J&K:FNXVO8[/`IW,AF"4[(`UV\JMA5$.O*?+3(@(]IM0043_KP MGQ']W>6Y*S,IUU(I84\=B2]=L.RLWAHA>6;4HWY>5V8BK*BS(2YP`U M%);5:_0"IU(0*(NG=1``6K";3A?W.19IM%OAL3*.)MD,QFU`%_0V5DU2X)O- MHO>)4W1BO0_<,'XOYC!CM/PHYTRX4F&?!=RRT!Q0N):;"=_S['"KM9,6^@B/:W(8$M1Z86'/:J M9Q&YXM7.$MB.**YP3H2-[W&*B^)R23,ENMD3$A,R9(0KHV"B1!<*#1ZZ^4BY M)&D]T`8XB3ID*(JH.BRYIR>I9V[#?'H*]=U+J&!6M&*+1\8K>.+%7IFI" M2"1#FS3".4JS]"`TF!QM4;3)>14P'^IO&?O'5KD*<^?HI$8%&T3NLH2\EX(& M@\NM7;$*#;^KJA5:E;3E*YJ$S#C764JW6HX?8UT6AY[/C5DI5%`B;E$C;,]"P$:8?#"C.95Q8C4Z@"FM M18LNP.2#?=K5!TP+4.HR#`1:V#0"B:BJ0FQL7?F%D[FN/J+J86%C6-F]D&4& MHIC.3X.$QG`OTNJ"TUYHZ/F`+_[7JR!>/%_3LXV!@XMT?TVO%P`R>B?B!?`F M+P0.6)]P&=`:P'5!^%Y$*1A`H:04NHNAFA#5E)Y`1]_K7 MQD)B?15WT`FB"L;"I%")82>[-:,?0V*J,1#JOVY2C(Y>+ZBK^,[5ONUPG:O8=KQ:!R';*:+;K??L79(_4C(0J))DB/)8 MLD=+3T,EFXAT8+L?:=6%E/P;EW&0H/7F)HE#6J`%LP9(LP%IF'B.*,BWW9]= M;OQ:6G]K^]?6]*=W4MP=LN^KTFWVGDK>AG-WI5+-PF?Q)OAO=9E"_SR7J:+C MW9=^;N#4E9EVPL<-#1I*?9?>;_GG8K2V:^)G](8[\XSH^B$;,R.B[,Y=C$2A MX3,BPN^77S'0KM>EH*!$OSLZ>OF'CE<)T@T=QX^87WGCF2\Q4'S$M*A\R("F M1?ZY+)4'L)X5-IHI.Y,*>U-1(WA,&4R.I M[_+/S6CM=]C,R-;A3!B:WE])%QVGT2=^U9[@&?OBTX:MP`>IC=63NZ@&.XO+ M5@U(-\8<1ZL':]KV43F67K[(_-2KEZ^^Z:S@>*#Z2#G5`@_IVN%9&M>U!+-O M!LO=RVB+K9KQT&1W"HZR6=Z*[T:KU'5"J_5L4\82X,-,N(/N$;/\?;)A8UR7 MW1:AHX:;N2O%U:2&-N?D#BZ/&"RWL-BET\HC-O\F%L&M(SFI$6ZR0N MR2243$8SE&<;EI"$-FM6'XB>Y6@V[&HF;MP5^SEWH.H40U79M619FF+V-7J( MRSM9SQ7-^3OQ25G.CMBY#W+JC;0U:>^QT%&>XA^;HJQKN\ESE`>?A)ZF<4@_ M-$UGB.:_:Y=5IVPGN*-&@KNSL]=F[FZ>[O'[!/!LH+B]S=G=]<01UD^@;J_A M%NE50_SR18X..DB8=99?VSF3.IF.8YS2PXSPHV>/.`_C`E_E<8C)=([YZ>H` M)O?61(S^#6?;9N!\H[V"P@Y"U0)B3=`U#Y_$[8X:U\%76A1CWKUG(\.?4.,U MTWA8^H@C9S^Y]HW%WE+?!W3I%V5)$N3%GLO1*G",<;<\U5#+GM4G-5>?NKS? M4V-HEG3A"=R6M9=H'9>3\A9#=1:[;0JW;G>[5SB)^:[M$[` MTH?I/0#0_$JS=6W;C$^^JZO@)/.K>7:Q)Y]?]6AL-K^2YZ%XZ[(LM3>;7]$^ M>((^2FK<@^=7$^72M!ZY*YC$`G326+^14S)IQY%7,E.QQRTURIGQ**YB:\P+ MKS12XYU;"HTVQOST3;!]X+=OLC!RM7.RL7"X??S+_#9(XU^9;9QD:9$E<<0K M,*31%9&SMIO+976?<9#LKDXRN<=[FO9!=_ZGZI*N;33;7:!6R\P6FFU3?[EK M'>V;]^(B/B\Z*!O009#Y`Y,:5C>Q8%JK@O,V[X(B+BZ7QV%(KTK57R@CTH)Z M`9FHXDTGA(::ZIX*?;G&CR5Z1S3YQ:&)FDN?64@/:3]*J'1M08V3$7/\OV2D MH1,J::XKM:6FA9NK*T3MOFU&ABHZI\/(/%*#S0QUT&C-_K2XF`B;U%R9M9J` MM%,GZJ_@1DM94\FOR8*3M$46'LUJ"C!52C@/L&=$4M!YL6QPI!YH7K\5 M+(6,?CM,PMX?'O.,.%K4.&."X92*=;H;W`V&(KMVP.\=MU%1=DREXN=ES)LM MH'T37HQB7B@+?3V[-8!E5[?;H]B&'`.N[DI\#\WM$S(O>&&EY(%=IZJ%EPL.U^3(D[KQ?@WFP*@<\T>^`BS MRS[LN$.^T8)-R>,4^]IUBX@=+\:4.75P:0']"ZQ>##FH7/8YQ&F0QYEIQ;(6 MO9M*91V1-46]:DJ_:GG)NEQ9PTO:WX`XJ1[_8UJL<1@O8QR=9JL@%B+T3465 M/+!XT8@N5G;GM`O4H$9?.+UKW/2]`@$[O?T/AY\/07@7ISC?DDDPO6]O33'] MESPK=,Y&PP2*(*WP70CMB-DZ9T>^0(S!W7!KI02M%;@I<8YP30E=='F&OE^@ M:_I$MU;<;PA=,S:P`M"]O\UJPPX8G^)U3MP*VZ-FFTOT*YUAO=F^PM4/X%\HL]8 MM$W"Z=[E7!WU'A?%6Q0TNBMJ/,&5!WMBR%!ZR=&]M3:O&O?D^NP=OHU36LD0 M5:7A7%:P>W*]=\9O0U)V'7!*PJ0CG"2!8=KA#6[P5\KR$>L&="T;Z"#=HT`7 M[!W8=E%+F-P-HY:JD&_1,GZD1Y**`I=SK$-^Q7GVTU,5WF@D]T]LBR%U!Q\T&C$1T(9!(2>@!+'Y-AU?[ M+ZJ>5^[!*+L=#C:\5@T-SV8ID:AW#T9.#PH7EEZW\8)>5MMLYBM4^:LOM"E4 MM>48CP-?L0]\N8"0JR(E[_8#IA>NZR%.3##;2U!906'VRG]$73N`8-;+. M%):20D]6,K\GU'\BG\E_-P0JY)?_!5!+`P04````"`!7=E5`*V,TDSX2```6 M)`$`%0`<`&-D8F@M,C`Q,3$R,S%?<')E+GAM;%54"0`#E?5#3Y7U0T]U>`L` M`00E#@``!#D!``#M75MSVS86?N[.['_0NJ]U;,EM$F>2[2BVE?&L8VEL)^T^ M<2`2DK"E0!6@?.FO7X#4A:(($"`I'8KU4Q(%`,]W/EP.#@X./O[Z//5;CYAQ M$M!/1^TWITC;0^_X_=&O__[G/S[^Z_CX]\]W-ZW+P)U/,0U; M7T69$<%>ZXF$D];57\??"7["K!70UL,<?[[5?M,^/J[\8YVWBH^=QA_S"?UCB#AN"4U0_NEH M$H:S#R&9DXW23V?+LNV3W[_>W+L3 M/$7'A/(047==2S:35:]]?GY^$OVO*,K)!Q[5OPE<%$;%CN6 M/QVW.\=G[3?/W#L2.OCA(PM\?(='K>C['\*7&?YTQ,ETYDNYH]\F#(\^';G> M<"(::+?;G;CZCTO%=JEW14,2OES34<"FD=!'+=GNM[OK#>E=@BD>(Y=A_,<; MBL,36>A$V\Y)22'O0Q1BV7I_U"-4T$&0/P@XD8U?^(CSJ'?9B&O88H6"7XMA M.<4%95Q4KE"<_@RSB!P^0$S\,L$A<9%?4#Y5:Q4*?('XI.<'3_R:>H1A-RPH MZG8[%0IY/Q'P)X'OB5GJZL^Y&`9B//2%.MA%,)V)_\*4DT=!#X@AQLI3/#%LM3/)V2,&)" M#`RA#MFZ,(HLI=4U4UZW0X[_G(NVKQYM>]Y673MALHP,G[&X;?FY$'O2Q#B7 M)D;[;23NXN<;-,2*X9VT5\XWVHHK[4W&`68D$!9(,6%3M?I+W%Q?2[JK<_O8IE$!?3Z[IFI=*&VY):*W-#B\)4X6(" MB\S&&R'&AH#X.<1BA?66(LH&RNY"Y%=_^.@'[L:7?+E#"UC>E"U_<73-=X<\ M9$B:I7%#OH0:->\8UW5.8]T82KE01Z3J$>+#2-]S?CQ&:'8BI3_!?LB7OT1X MCD_;BXWCCXN?G97A\H"&ZSZ1$#^[H-->RIHDLLLVY4;,7;8H_KK%XN8^=U'B M9!:9?,?NA/BK#C!BP=1>FTM9@APDK8`)P_/3D:@QYT+$8"8;DL:L`#?"C"T6 M,HWPD>2/F`V#C>$'0^6]BRD2:T+WF7`31I/EG0X0L6IV>L+FRF65*0J@%R\,0N52&6.WPM_FHT-E>%G9_K M0J7IP$R*OB2O78LYEF/WS3AX//$PB?D3?TG3)GYRXL7E#H^)7%-H>(NF64ND MJJCS2UTHVZ!BDS:-\,H1MQ^]7PC!&?*OA27X_!_\HE5\JJSS]J`TORV]>KSL M6O<74OLI9;?@77DE6M? M8\EDEG7:M=E!&W;M+?&7VG\/IOW8MHH%ZXG?LC:^VO).NS:;7T,6,B$LF3@' M9D):N>8\K$H[[4/9SVH`K#=6V21\/$F?3.SLN,(P"@G.494AE^:?!#C6UV="QN2]\0,F58K(QS$W_(\,M'Y$>1;^$%8NR%T/%WY,]U M*Z91??#C$"6)V9R;@FI(']C0CNE`!C]HL>0T+7QEYY)A*J!MK]0-6###+'P9 M^"@.BA'==2;7IUML,C6;5`<_SS&=J0W!U.M`NCCU7Y'0&\7L)0GU"PNXSAQ6 M5P(_.S*E+YM\+;"FS-.N.Y_.?1GM>8F%Y&([*'&(O_LX(HMZW6G`0O)7]+M2 MH;HIOJ)/@)^/E>M-%:JA*=.-3J$%5QCX8[MRO20/FSJ*P)+ZOS`+OM?!1KP- MJ&MH)JZ+PA\2EIP,,O"H0Q4.:U3'V'+)A#^"M-NN)\\>2X\^4`/_AJ`A\4E( ML(FW+*-T+<\QE3XS!8"F+**+:X]\@%ZD[U>:$:[+YD+X-6Z#?;AY*_#GIRI& ME8:7#;2&&/:7<_P0W.'(WAP@9M8+U)7@CVOM2-UZ MLZ-7`Z.R-1J8VP0ZL]79:4-[U>PX3(E>F?D+:EMMYYXP"G)057+:T"XT&TM+ MCZ,I`S,1:9M[DI4JZK2A?5@Y%"G.KC)@-,1,ZGH>B04?(.)=TPLT(V+Z2"#6 M&-T M#9U)7;IQIP/MZRK4AZH!7G[14.:0`;8+K.P!IP/M+"O4![*!-,/22QJ[U+/B M-Z^JTSE4_YH*S5)06TVCH8,V0$+1ICS2/0>UDZR MZ:+@L<\%R,S``#\\%?D6T[(FS@:SMFJY=(9\"<^;$AHE)`O)(UYH3-,) M@V0J7.?'18T_,U?<0\ M>@XCAGHM3P;%+UHW=G85^$AD,^:R6=>A`M\1*_91%_(%,]^/U-P?7>*A,DO] M=DGXR.$B;&G`P.]V*[*3$:%RB>G32\)GBVPP_5'N30YM/?B0X3)C,Q=:4S;, M$:+KZ0P1)F>BBPEB8ZW%G%T!/H*X#-MJ3.4WPO4(0%%JIXBM!1]J;'.,;]Z%H-"@"<4L9=(@_(ZHJ@I MT/B1I@RLLIU]];`"GW>LB&8$3*W`+T;?9TSQB.3WKZT:=8BBMNT;F2":XF^[ MQ:&1W[PQ*^%,=.\ZU39:=WCIYJNJ9@,D;SO'O]I,-,4::X^)JF!IZT@P(;T MEEL<2N0#%CP2L99^?OG&L8"]"ACKNB%Y-$W,:-\8N,5;E'VE3]Y>`0R@:$;4)?X>`/L0U#=)+*+SX%?9:NRF^U( M0?#;]XH.]3F?R]#(_BC:RHK)_3?$&!+:Z@7L'K-'XF+>9Q<^(EKSUJH=\+MW MN^H4B@@"2]V`SX2["!V&#@?:#^5J].4GC'K$(>[O?B9TD-!^)PESK;P&+J>" M?*'CD/;;4=1::,H#%#NZS0#M/-UO-\E51OG@Q7HL2&F_0T)?B[2G9FG6#!N! MOYZX9^/52C.5155";XNV4`\8%E.NEW_I(J\J_)5'2TI-^\4VS-(;F;K.,*DG M2:QZ0ZHN_)W*'76'#)Q-<9J8^Z$`M&8'0Q M]J+;C?=B[/5'A?J,>2OPUS^K[31VR)LRTYCKL)+E"OY>:*6=Q@YXHPV='J&( MNA49.IK&X.^D[L70R=%`4PX(DK-N,MNIXN31I!K\M=:"E.:O2UE0P4^2J[5X M>P&[P[,Y>8\\I5?&?Z^:[6=P@AP4\ZCDT-@'6AAV#7RZL(_Y+.S MZ4*)MRFKA[GF*C%!G`ZT'[?2KF('O!D);FQLMXKN`#@=:-=NM0:K+?8F=YRN M&$&,O8C!DOO,K$E]IP/MQ"U_3R0#4F6^DEG4R82,+&QX/X#VQ^Z@'U28QR_N M!U<4[JG0^6SF1_I!_O*6Y#4=!6P:$V5P7]6L!:<#[62U>ES<'%13`MF6.0#E M(\S:&(%U,:<#[0.UX4D5"[")IR%>B$3RQUQ"-THZ9]!>R2HXW8+4F%..@+I" M)VN_//56VYQH3C-[U<"L#><,V@%9OB]8@6V*.R'RCTBG"?;:NJ4[4Y%9TS:-=8Z>G;".,.\XW# MI!2+VZWDDEEBZTJ[IXI95+JG:>N"YP0H2G`>JLATL M%-MW.!0F._:6;U3DTIQ=`3SW5T%^E6@JVZM"$9O20VY.\LSRX+FV"M*J`E/9 MT1T4JV63NM;F<-X^J>N[QK@+M_<&>2[[C<+@R:JRR='XY]/B5V4BU2"H9NL5 M'QV5Z;+@2:2LF,R0ODGA48F3I,LY$_CBN,`H!.@6/T7_HY]M#>K#IX.R'KPF MD*J['B:?+:A9#X@[?HDND&H`/M>3.:]6_2(#9U4S?<%^H7PK3(T_RGB)7=RG M68Y'F^KPN9A,QKHM(OCH-SM2XTX9_;Y(9FK/;&8;\)F2RM*KA`7_>VOR-:P5\2#HW2WB)N!3R]DRW69'K/&#'XH MJ5@KUN8&M*^D,/@%S"^4;Y#+MD1,0F.2]Z2EFG/I&M:984 MI&J`'#RQ)8.G:G,J8!\\58?7#10.@ZMGS%S"\8`1%P\PB\RMQ;H2^SO6[Q!J MCNXLFZE/P.H&21D^`'M@X*MI8::3SDA=P$69YNH3TUJ>>17`1@QVS7&?93/U M"7NMVE,P\BC+@V:*>.X;$&9)LAJVWTS:;PC]+1&'7: M^YE/PHN`RE^$H'>2#!73-FW4,70VFV5+5,VX12UP>?*=M>4]<^2O],7W[T#J MLS&BBQ=KA60\\(FW?+YVD$#?'V6(:^!@JJ1]$`?49\0)[X\6KZ'IW;A;9<'= M4%7I7;&/R@*\.]MZCZ/S2R!?SPNHBQFU&8V*N3_9G&:T*,M:]GP#*1Z$8C[[ MV>G5U87!^K-.,UE+BDKZ1G3.^_ETBMB+,'K)F)(1<>431JLA.!!CW)59T?=_ M+WI+!H.505T)YKQ!IU+=H+%K`'QAT*I=Y34SA=:(42:M4A)'EL@$R$&$%E.8 MH:41YI)PUP_XG&&#T6;5#L@`-)+09"#:-00^(&V948Q1:]2-&*OW\R''?\Y% MLU>/,!NHM`1&6<*SJ\"L>REAC)8Z51WPP:11K6IMTV#9\Q#Y>"(E'"*.Q3_^ M#U!+`P04````"`!7=E5`&5-7+=P'``",-P``$0`<`&-D8F@M,C`Q,3$R,S$N M>'-D550)``.5]4-/E?5#3W5X"P`!!"4.```$.0$``.U;;7/BNA7^O)WI?U#Y MTG;F.@;2[-XPR=YA$[AE)@D,L-OM=#IWA'T`=6V9E>00^NM[)-O8!MLQ);U- M[O!E(ZSSG+='.M:+]^JG)]\CCR`D"_AUHW76;!#@3N`ROKAN?)[VK1\;/WW\ M_>^N_F!97S^-[\AMX(0^<$7N46;.P"5KII:D]V_K"X,U"!)P,@U!NG3S`^G# M3(14;$B[]0-I-UMMTKSL-#]T+MID=)^J^A*9)ZVS<\N*C15TMK>=+^=)^WV) M)ZT7-W;1.?]08JP9&9/.$GQ*P`/=WP^$?PMS&GKJNO$]I)ZQVR!(&)?7C:52 MJXYMK]?KL_7Y62`6=KO9;-E?[^\F1DTLV/$8_Y:3?IH)+Y$_MW7WC$I(Q'6O MJ[:`K/"%'75N1;T*O5_O4'%6*:L09EPJRIW4B3VGXQ!;EY>7MNE-1#DLJ`*W M5/FE+0(/[%@L08726E"ZVJ+F5,X,(NY`9*ME-5O6>6L'8E&ERF'8*=@L5"`3 MF!.$7(E-/J$2G+-%\&C'G076G%`(G(=EN+BW`.@"*\9@1X$X/#G+8GG=4P!@ M_!&D*H9$?04@3IDCBS&FJP`BF5,,P(YB=M1F!;*0&M-39$.M1(D1["D`")B7 M#K3W-O:F+*P$.,\,3"H<,S;GU%$6/*T\RJD*Q*:/O[>9"S@/_6(EKA*V#LU& M(0NE0#`GG1;J^2F16GG>1*)>4;$`]4!]D"OJ0`[F,-#SS!$`W\Y0OYL61.!]?#=%>4\4%1AD?QX15!?O[NW94N`1T=QA2]([KQ>3RH5FV" M3HIOE[L]KIC:#%"G\(V-!F%(5Z5$9#TV[\*<<6:\P\I+K+2R8W-X\_F^]S`E MW8=;@G\'T[^3P4-_.+[O3@?#ARM[5T-6<2C!'?*/IHWC2*)*8UZ7U!@9BY2A M4L7U,0[UG-"K,A0_2M)^)!43#,J\Z(;S/N-8_AGU1H$T7M]X5,KX?:=)J2E; M3D\;.=DJP?:G[EWWX:9')G_M]::3$QTY.@:X`/1A+_/QX_(DG^\D>3+M3GMZ M%DS(L$^&H][8#/Y3NO/I'JY`&,-R1/&UKI:@&+JSE_\RN7)"_E*3$/*/G,9_ MG@C*$71#Y;+O!6LYX"[#][K:HV9?HIR4BUU2MNU@3K0B8C2=.,AQ,%GB"%T& MGHN;IM[W$-_+^((>XH@5-X&/&5@"E^P12DK78>AR[MZ7<21,5.-]B*W\D MD1WR)]S#,8>I/Y\(S1.:25:4JCA1U46P)JRD/.>7NSDW..)$P%-JL8"%OD_%!NL06W#<=#@4=XJ..N=&GR?:9,5<"W/8Y^G2'@ M*4%5`N6LM'99R:@AE+LDI^A$A)XT,PG?0PRN]YB^%_:>EJ>\O3\1$BR)P+^Y M-.M_]+G\&.;$''AW]#G<=4,R?^7I@W+S;&E.)/6QFI6V41WH0(([T('BF[Z:IA.`MGE1QUKEA5N) M46.P$&B#IV3RQ$I5U8Z[X@:KRID"6-P^QHFB6\$Z7F1QR8^C_"BZ9:SE2!:X M_76,*WN7D774=>RGJ*AYC`>[MYYU["<8W3C*]NYE:"WC"%)]-]V=225HA MEVB_U!./UGGF$YT./L.=ZT"!K_N&$J%>!1HI7'>QP)T:G!N*^/*< M,P_7J'K=%LE*W*.AT5#W_BR"<)488:B^,+R1".8@]3=1U.L#R#%X>N:.J%"; M3%C58MEP_`!G'Q6;HH#FU)//1!3US:BGUW/8`3.F7B+.&ZW/B]:_P_DMS+*D M%77^[V+"G;K[,D']#=ABB31T'T'0!>"HGH$8SO7A2,#-_8L>O;@OF["&@US-SL^R,07]."N8J M9;+RF+H)>/R!Z5@;S([U@V#UPOU5J.UC$6>/P+$,17.T+P*_I%S5D'T+\]L0 M,Y`R!/&'')#N2;B#8)M],9<)O`4ZN^Z_0AE=T4R# M-)`19>Z`W]`54[B4/*"FOY"^MY"ZWA,(ATD8X1X%<#@;\N/O,*(A@($6UKZ# MD5$Z<".E8S32_[?9\+SOV?G]`&OS4!X4?8F&-Y6%E,%\(3P8^5JCSN\\QK`* MA;.D$O&UL550%``.5]4-/ M=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`5W950!CF+$FE!@``9DT``!4` M&````````0```*2!=AP``&-D8F@M,C`Q,3$R,S%?8V%L+GAM;%54!0`#E?5# M3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`%=V54#PL?)9\0X``%?E```5 M`!@```````$```"D@6HC``!C9&)H+3(P,3$Q,C,Q7V1E9BYX;6Q55`4``Y7U M0T]U>`L``00E#@``!#D!``!02P$"'@,4````"`!7=E5`85$R()P@``#;R0$` M%0`8```````!````I(&J,@``8V1B:"TR,#$Q,3(S,5]L86(N>&UL550%``.5 M]4-/=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`5W950"MC-),^$@``%B0! M`!4`&````````0```*2!E5,``&-D8F@M,C`Q,3$R,S%?<')E+GAM;%54!0`# ME?5#3W5X"P`!!"4.```$.0$``%!+`0(>`Q0````(`%=V54`94U

XML 26 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 62 82 1 false 3 0 false 3 false false R1.htm 001 - Document - DOCUMENT AND ENTITY INFORMATION Sheet http://www.cienegacreek.net/role/DocumentAndEntityInformation DOCUMENT AND ENTITY INFORMATION true false R2.htm 002 - Statement - BALANCE SHEETS Sheet http://www.cienegacreek.net/role/StatementOfFinancialPositionClassified BALANCE SHEETS false false R3.htm 003 - Statement - STATEMENTS OF OPERATIONS Sheet http://www.cienegacreek.net/role/StatementOfIncome STATEMENTS OF OPERATIONS false false R4.htm 004 - Statement - STATEMENTS OF OPERATIONS [Parenthetical] Sheet http://www.cienegacreek.net/role/StatementOfOperationsParenthetical STATEMENTS OF OPERATIONS [Parenthetical] false false R5.htm 005 - Statement - Statement of Cash Flows Sheet http://www.cienegacreek.net/role/StatementOfCashFlowsIndirect Statement of Cash Flows false false R6.htm 006 - Statement - Statements of Stockholders' Equity (Deficit) Sheet http://www.cienegacreek.net/role/StatementOfShareholdersEquityAndOtherComprehensiveIncome Statements of Stockholders' Equity (Deficit) false false R7.htm 007 - Statement - Statement of Stockholders' Equity (Deficit) [Parenthetical] Sheet http://www.cienegacreek.net/role/StatementOfStockholdersEquityDeficitParenthetical Statement of Stockholders' Equity (Deficit) [Parenthetical] false false R8.htm 008 - Disclosure - Interim Unaudited Financial Statements Sheet http://www.cienegacreek.net/role/CondensedFinancialStatements Interim Unaudited Financial Statements false false R9.htm 009 - Disclosure - Going concern Sheet http://www.cienegacreek.net/role/GoingConcern Going concern false false R10.htm 010 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.cienegacreek.net/role/SummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R11.htm 011 - Disclosure - Commitments and Contingencies Sheet http://www.cienegacreek.net/role/CommitmentsAndContingencies Commitments and Contingencies false false R12.htm 012 - Disclosure - Subsequent Events Sheet http://www.cienegacreek.net/role/SubsequentEvents Subsequent Events false false All Reports Book All Reports Process Flow-Through: 002 - Statement - BALANCE SHEETS Process Flow-Through: Removing column 'Sep. 30, 2011' Process Flow-Through: Removing column 'Jun. 30, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: Removing column 'Sep. 30, 2010' Process Flow-Through: Removing column 'Mar. 31, 2010' Process Flow-Through: Removing column 'Mar. 31, 2009' Process Flow-Through: Removing column 'Mar. 31, 2008' Process Flow-Through: Removing column 'Mar. 31, 2007' Process Flow-Through: Removing column 'Aug. 16, 2006' Process Flow-Through: 003 - Statement - STATEMENTS OF OPERATIONS Process Flow-Through: Removing column '3 Months Ended Sep. 30, 2011' Process Flow-Through: Removing column '3 Months Ended Jun. 30, 2011' Process Flow-Through: Removing column '7 Months Ended Mar. 31, 2007' Process Flow-Through: Removing column '12 Months Ended Mar. 31, 2011' Process Flow-Through: Removing column '12 Months Ended Mar. 31, 2010' Process Flow-Through: Removing column '12 Months Ended Mar. 31, 2009' Process Flow-Through: Removing column '12 Months Ended Mar. 31, 2008' Process Flow-Through: 004 - Statement - STATEMENTS OF OPERATIONS [Parenthetical] Process Flow-Through: 005 - Statement - Statement of Cash Flows Process Flow-Through: 007 - Statement - Statement of Stockholders' Equity (Deficit) [Parenthetical] Process Flow-Through: Removing column '9 Months Ended Dec. 31, 2010' cdbh-20111231.xml cdbh-20111231.xsd cdbh-20111231_cal.xml cdbh-20111231_def.xml cdbh-20111231_lab.xml cdbh-20111231_pre.xml true true